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Abstract 
Nanotechnology has rapidly entered into human society, revolutionized many areas, including 
technology, medicine and cosmetics. This progress is due to the many valuable and unique properties 
that nanomaterials possess. In turn, these properties might become  an issue of concern when 
considering potentially uncontrolled release to the environment. The rapid development of new 
nanomaterials thus raises questions about their impact on the environment and human health. This 
review focuses on the potential of nanomaterials to cause genotoxicity and summarizes recent 
genotoxicity studies on metal oxide nanomaterials. Though the number of genotoxicity studies on metal 
oxide/silica nanomaterials is still limited, this endpoint has recently received more attention for 
nanomaterials and the number of related publications has increased. Analysis of these peer reviewed 
publications over nearly two decades shows that the test most employed to evaluate the genotoxicity of 
these nanomaterials is comet assay, followed by Micronucleous, Ames and Chromosome aberration 
tests. 
Analysis of the literature shows an increasing number of genotoxicity studies for nanomaterials every 
year.  Based on the data studied we concluded that experimental data for genotoxicity for 
nanomaterials with the same core chemical composition, may vary to some extent due to: 1) variation in 
size of the nanoparticles; 2) variations in size distribution; 3) varying purity of nanomaterials ; 4) 
variation in surface areas for nanomaterials with the same average size; 5) differences in coatings; 6) 
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differences in crystal structures of the same types of nanomaterials; 7) differences in sizes of aggregates 
in solution/media; 8) differences in  assays; 9) different concentrations of nanomaterials in assay tests; 
10) variation in concentration of analytes in assays. As a result, due to the considerable inconsistencies 
in the recent literature and the lack of standardized test methods - reliable genotoxicity assessment of 
NPs is still challenging. 
 
Keywords: comet assay, micronucleus test, Ames test, nanoparticles, nanomaterials, metal oxides, silica 
1. Introduction 
Nanotechnology is currently utilized in many areas of industry, medicine, and military applications [1, 2]. 
Nanomaterials (NMs) form the basis of nanotechnology and may be described as materials “with any 
external dimension in the nanoscale or having internal structure or surface structure in the nanoscale”, 
where the “nanoscale” may be considered to be 1-100 nm [3]. However, it should be noted that 
variations of this definition exist [3]. For example, the recently proposed definition from the European 
Commission takes account of the fact that NMs will typically be composed of particles with a 
distribution across different sizes [4] and particles with larger sizes, up to 1000 nm (to include 
aggregates and agglomerates), may also be considered to be NMs [5]. Nanoparticles (NPs), as a sub-
category of NMs, may be defined as particles with all three external dimensions in the range 1-100 nm 
although, again, variations on this definition exist [3]. The special physicochemical properties of NMs 
due to their small size and structure confer novel capabilities to these materials, suitable for a wide 
range of applications [6-12]. The development of NMs is also driven by hope that these chemicals will 
offer improved performances and new functionalities leading, e.g., to smart drugs and to their aiding in 
achieving sustainable development, e.g., by reducing the consumption of energy and materials and 
reducing environmental contamination [13]. At the same time, despite the huge benefits of 
nanotechnology, there is current concern regarding NMs’ potential hazardous effects on biological 
systems [14-20].  
The same properties that make these particles exciting for technological research and development may 
also make them problematic from a toxicological perspective: NMs are relatively unexplored with regard 
to long term, low dose, exposure [1, 15, 21-25]. However, it should be noted that the question of 
whether or not NMs exhibit novel mechanisms of toxic action is currently a subject of considerable 
debate, as noted in the recent paper of Donaldson and Poland [26] and elsewhere within the literature 
[1, 27-30]. Even NMs that have the same chemical composition differ in their toxicological properties; 
the differences in toxicity depend upon NMs’ size, shape, and surface charge, type of coating material 
and reactivity [16, 31]. The potential toxicity and mechanisms of toxic action of NMs are still topics of 
particular interest due to the lack of sufficient toxicity data and mechanistic understanding. Indeed, 
uncertainties around the safe use of NMs are considered a major obstacle to innovations and 
investment in nanotechnology [32]. 
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As well as hazard considerations, exposure is also a critical factor which affects the risk, to the 
environment and human health, associated with the use of NMs. As for conventional chemicals, a 
thorough risk assessment would require “effects assessment” (i.e. determination of the toxicity 
associated with a given dose, exposure duration and exposure route) in a toxicology study followed by 
consideration of realistic exposure estimates for the environment and human populations [33]. In 
addition to challenges associated with environmental/human exposure estimation [34], “effects 
assessment” is complicated for NMs, as compared to conventional small molecule chemicals, by 
problems with the toxicity data as well as the challenge of determining appropriate dose metrics [35] 
[26].  
Since the available data on NMs’ toxicity (the focus of this review) and environmental/human exposure 
[34] are unfortunately limited, they do not allow for significant quantitative risk assessment of the safety 
of synthesized NMs to be made. Moreover, the problem of the lack of data becomes even more 
complicated by the questionable suitability of tests used for NMs’ toxicity evaluation, including the 
common genotoxicity tests which are the focus of this review. For example, some inconsistencies in data 
from different tests are found in the supporting literature and the validity of some OECD genotoxicity 
Test Guidelines for NMs has been called into question [36, 37]. Indeed, the OECD Working Party on 
Manufactured Nanomaterials is, at the time of writing, currently reviewing possible modifications or 
additions to existing  OECD Test Guidelines and/or OECD Guidance Documents for a number of different 
(eco)toxicological and physicochemical endpoints which may be required for NMs [38-40] [40]. 
It should be noted, when considering the toxicity of NMs, that a variety of different kinds of NMs exist. 
NMs may initially be differentiated based upon their chemical composition. For example, Stone et al. 
[41] suggested NMs might be categorized as carbon based (e.g. carbon black, carbon nanotubes and 
fullerenes), mineral based (e.g. metals, metal oxides), organic (e.g. polymers, dendrimers and surfactant 
coatings), composites/hybrids (e.g. multicomponent NMs, such as quantum dots, or doped metal/metal 
oxides) with nanoclays suggested to be difficult to assign.  
In this article, we concentrate on metal oxide and silica NMs for which experimental investigations were 
reported in the literature and summarize the in vivo and in vitro studies of genotoxic effects that these 
NMs exhibit. Metal oxide NMs are an important group of engineered NMs, as they are used in various 
areas of human life such as cosmetics, sunscreens, self-cleaning coatings, textiles and paints. Other 
applications include their use as water-treatment agents, as materials for solar batteries and, more 
recently, automobile catalytic converters [42]. Silica (silicon dioxide) based NMs are also of significant 
commercial relevance, as recognized by the Organisation for Economic Co-operation and Development 
(OECD) [43], and concerns regarding their use in cosmetics were recently raised by the European 
Commission, which requested a safety assessment of “nano silica” from the Scientific Committee on 
Consumer Safety (SCCS) in October 2013 [44]. Whilst there is precedence in the nanotoxicology 
literature for considering silica to be a metal oxide [10, 45], silicon is technically a metalloid [46]. It is 
included in our review due to its various industrial applications. 
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The importance of metal oxide/silica NMs is demonstrated by their large use in consumer products. 
Indeed, according to The Project on Emerging Nanotechnologies online database [47], at the time of 
writing 1809 different products containing NMs (including metal oxides) are currently marketed. 
Moreover, it is expected that the nano-market will grow exponentially and will reach an annual turnover 
of $2.6 trillion in 2014. As far as metal oxide NMs are concerned, their widespread use is highlighted by 
the fact that five classes of this specific category of NMs are represented in the repository. To be more 
precise, 180 out of 1809 (i.e. 10% of the total number) unique consumer products found in the 
aforementioned online database are metal oxide/silica NMs, including titanium dioxide (91 products), 
silicon dioxide (41 products), zinc oxide (38 products), aluminium oxide (8 products) and cerium oxide (2 
products). 
NMs represent high tonnage materials. For instance, Hendren and colleagues [48] estimated upper and 
lower bounds for annual U.S. production volumes of five classes of NMs, including cerium oxide and 
titanium dioxide. The results of this investigation showed that titanium dioxide NMs was estimated to 
reach the greatest annual production among the considered NMs, ranging between 7,800 and 38,000 
tons/year. Furthermore, a study of the Dutch National Institute for Public Health and the Environment 
(RIVM) estimated the amount of NMs used in consumer products on the market at the time of their 
analysis (2009) as well as the amount of NMs which were expected to be used in consumer products in 
the near future [49]. In order to assess the most relevant “exposure characteristics”, i.e. factors of most 
relevance to estimated exposure, within the considered categories of NMs, a working group of seven 
RIVM experts on NM consumer exposure was consulted. The individual estimations from the seven 
experts were combined with the ranking of NMs in consumer products, based on the amount used 
within all considered products, as well as data from product inventories to identify high priority NMs for 
future exposure studies. As a result, product categories with a high priority for future exposure studies 
were as follows: sun screens (which often contain zinc oxide and titanium dioxide NMs), coatings and 
adhesives. In addition, cerium oxide (motor vehicles consumer category) was labelled as high priority as 
well as titanium dioxide and alumina contained in cleaning products. 
Many industrial chemicals are capable of causing  genetic damage to living organisms [50].The potential 
for NMs to exhibit genotoxicity has been discussed in several reviews [17, 51-55]. Among them, metal 
oxide/silica NMs were found to cause genotoxicity in some, but by no means all studies [17, 19]. Various 
kinds of features can influence the mechanism(s) of metal oxide/silica NMs’ genotoxicity - for example, 
their size, surface charge (and other surface properties), composition, shape, solubility, aggregation and 
agglomeration [41, 56]. All these properties can affect both primary and secondary genotoxicity [57]. 
(Primary and secondary genotoxicity mechanisms are discussed in section 5 of the current review.) A key 
genotoxicity mechanism that is often described is ability of the particles to cause oxidative stress, a term 
that can be described as an imbalance in the oxidative and antioxidative status of a cell in favor of the 
former [11].  However, there is a need for a more detailed understanding of NM toxicity mechanisms, 
including genotoxicity, and an appreciation of how the physico-chemical properties of NMs are 
responsible for interactions with cells. Therefore, there is an urgent need for as many toxicity data as 
possible to ultimately allow for the risk assessment of metal oxide NPs to be undertaken.  
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Despite the need, obtaining reliable genotoxicity data for NMs, including metal oxide/silica NMs, is a 
challenging task as there are many various complications associated with their testing. A number of 
short term test systems, which were originally designed for conventional chemical compounds and have 
subsequently been applied to NMs, are available for the assessment of genetic hazard [2, 13, 17, 19, 51-
54, 58-61]. These systems are often characterized by the endpoints that they measure: gene mutation, 
chromosome damage, or deoxyribonucleic acid (DNA) damage [13, 17, 52, 54, 58, 60]. At the same time, 
none of these tests are ideal for the estimation of NMs’ genotoxicity: some show low reproducibility, 
some need specifically adjusted protocols for NMs and discussions on this are ongoing as indicated 
above [2, 13, 58].  
In this paper, we have gathered and discussed the latest experimental data on metal oxide/silica NMs’ 
genotoxicity. In updating this fast-changing research area, we concentrate in particular on the discussion 
of genotoxicity study calls among these metal oxide/silica NMs, methods of investigation and possible 
mechanisms of genotoxicity. The genotoxicity profiles considered in this paper are based on common 
test systems used for genotoxicity studies: the comet assay [62], micronucleous test (MN) [63], Ames 
test [64], and chromosome aberration test [65]. When considering the data from these assays, the 
potential limitations of these test systems for NMs must be remembered [37]. 
 
2. Metal oxide structures and key physical properties of their NM counterparts. 
A metal oxide is a chemical compound that contains at least one metal atom and one or more oxygen 
atoms. The metal oxides can adopt a vast number of structural geometries with an electronic structure 
that can exhibit metallic, semiconductor or insulator characteristics [66, 67]. Oxides of most metals 
adopt polymeric structures with M-O-M crosslinks. Moreover, because these crosslinks are 
characterized by strong interactions, the solids tend to be insoluble in solvents, though they are 
attacked by acids and bases. In metal oxides, the coordination number of the oxide ligand is two for 
most electronegative elements and 3–6 for most metals [66]. (WHAT ABOUT METALS FROM THE FIRST 
AND SECOND GROUP?) A selection of representative structures of metal oxides are shown in Figure 1. 
Some metal oxides are composed of oxygen atoms bound to transition metals (for example, titanium 
oxide, Figure 1a). These metal oxides are commonly utilized for their catalytic activity and semi-
conductive properties [68, 69]. Transition metal oxides are also frequently used as pigments in paints 
and plastics, most notably - titanium dioxide [7, 70, 71]. Transition metal oxides have a wide variety of 
surface structures which affect the surface energy of these compounds and influence their chemical 
properties. Interestingly, there is very little known about the surface structures of metal oxides 
(transition metal oxides), however their bulk crystal structures are well researched.  
Metal oxide NPs mostly have similar crystal structures to bulk-sized metal oxides but with particles sizes 
between 1 and 100 nm [72]. A metal oxide of NM size can have a very large surface size, which affects 
its reactivity and other physico-chemical properties. In order to display mechanical or structural stability, 
a NM must have a low surface free energy. Due to this feature, even phases that have a low stability in 
bulk materials can become very stable in nanostructure materials. For example, this structural 
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phenomenon has been detected in TiO2, VOx, Al2O3 or MoOx oxides [67, 73-76]. Size-induced structural 
distortions associated with changes in cell parameters have been observed, for example, in NMs of 
Al2O3, NiO, Fe2O3, ZrO2, MoO3, CeO2, and Y2O3 [76]. The second important effect of size is related to the 
electronic properties of the oxide. In any material, the nanostructure produces so-called quantum size 
or confinement effects which essentially arise from the presence of discrete, atom-like electronic states 
[67, 76]. Thus, in their bulk state, many oxides have wide band gaps and low reactivity [77]. A decrease 
in the average size of an oxide particle does, in fact, change the size  of the band gap, with a strong 
influence on conductivity and chemical reactivity [78, 79]. This can dramatically affect  the behavior of 
metal oxide NMs and their interactions, including interactions with biomolecules of cell systems [80]. 
 
Figure 1. The crystal structures of selected metal oxides: (a) TiO2, (b) Cr2O3, (c) V2O3, (d) MnO2. 
 
3. Methods used for in vitro genotoxicity studies 
This review considers experimental genotoxicity data for NMs. Most of the data obtained were from 
three methods used to test primary genotoxicity (as opposed to secondary genotoxicity, which is 
discussed in section 5): the comet assay, micronucleus and Ames tests. The chromosome aberration test 
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is also discussed briefly, but limited data were obtained from this test and so it was not considered in 
detail.  
The data obtained for the comet assay, micronucleus and Ames tests are summarized in tables 1, 2 and 
3 respectively. In these tables, each row contains data for all nano metal oxides (or silica), reported in a 
given publication, with a single core chemical composition. If a paper comprised results for NMs with 
more than one core chemical composition, these data were spread over different rows. However, one 
single row of the table may summarize data for multiple NMs, reported in the same publication, 
corresponding to the same core composition but with differences in other characteristics such as size, 
surface functional groups etc. Hence, the column “Result” indicates whether any of the NMs, 
corresponding to a given core composition and reported in the corresponding publication, produced a 
single positive result in the relevant assay (i.e. Comet, Micronucleus or Ames depending upon the table). 
In other words, if a row contains data for multiple NMs with, say,  different sizes or surface coatings, but 
the same core chemical composition, the “Result” column will report a positive overall result (i.e. “+”) if 
at least one positive result was reported for one of the tested NMs described in the current row. On the 
other hand, we reported a negative overall result (i.e. “-“) whenever all the data points included in a 
single row are negative.  We undertook this approach considering that in the majority of the 
publications analysed in this review, the metal oxide (or silica) nanoparticles of the same core chemical 
composition did not show different genotoxicity study calls (i.e. positive or negative) in the same test. 
For instance, Balasubramanyam et al tested two aluminium oxide NMs with nominal diameters of 30 nm 
and 40 nm. The results from the comet assay showed a statistically significant increase in percentage tail 
DNA in comparison to the control group, i.e. a positive result, at 1000 and 2000 mg/kg dose levels after 
4, 24 and 48 hours with both aluminium oxide NMs studied [81].  
In a few cases, the data were not clear, so the “Result” column reports “+/-“. For instance, Downs et al. 
[82] tested two amorphous silica NMs with different sizes in an in vitro micronucleus assay for 24 hours 
of exposure, at four concentration levels: 31.6, 100, 316, 1000 μg/mL. In this publication, no increase 
was observed in the percentage of micronuclei at the lowest concentrations, for both of the NMs 
described above. This outcome was also observed for the larger silica NM when tested at the highest 
concentration. However, for the highest concentration tested (i.e. 1000 μg/mL), the author was unable 
to score the percentage of micronuclei for the smallest silica nanomaterial reported in the paper, since 
the test material excessively precipitated on the slides. In such a case, we labelled the results for the 
corresponding set of nanomaterials as equivocal i.e. the “Result” column reports “+/-“.   
Here it should be noted that, in addition to in vitro tests, in vivo versions of the comet assay and 
micronucleus tests also exist [37]. In vivo data are also available [51, 59, 60, 63, 81, 83-89], but they are 
quite limited and where available, they were reported in table 1.  Below, we give some general 
information on the genotoxicity tests which are the focus of this review as well as a brief overview of the 
chromosome aberration test. This test is not the focus of the review and therefore not further 
discussed. 
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3.1. The Comet Assay 
The comet assay (also known as the single-cell gel electrophoresis assay) is a method for measuring 
deoxyribonucleic acid (DNA) strand breaks in eukaryotic cells [90, 91]. Cells are embedded in agarose on 
a microscope slide and lysed with detergent, containing a high concentration of salt, to form nucleoids 
which contain supercoiled loops of DNA linked to the nuclear matrix. Electrophoresis at high pH gives 
rise to structures resembling comets, as observed by fluorescence microscopy; the number of DNA 
breaks is reflected in the intensity of the comet tail relative to the head. The probable basis for this 
phenomenon is that DNA loops lose their supercoiling upon breaking and are able to extend toward the 
anode [58]. One way of quantifying DNA damage using this assay is via the so-called “Olive Tail Moment 
(OTM)” which is equal to the percentage of DNA in the comet tail multiplied by the length of the tail 
[92]. The assay has found a number of applications: assessing novel chemicals for genotoxicity, 
monitoring genotoxin contamination of the environment, human biomonitoring and molecular 
epidemiology, and fundamental research in DNA damage and repair [90, 91]. The specificity and 
sensitivity of the assay are considerably increased if the nucleoids are incubated with bacterial repair 
endonucleases which recognize specific kinds of DNA damage and convert DNA lesions to breaks, 
increasing the DNA content of the comet tail. As well as detecting DNA strand breaks caused by a 
chemical of interest (for example, a NM), the repair activity in a cell extract can be determined via either 
incubating cells after treatment with damaging agent and measuring the damage remaining at intervals 
or by incubating the cell extract with nucleoids containing specific damage [58]. Tice and colleagues 
reported that modifications to the traditional comet assay can be suitable to investigate specific 
categories of DNA damage. In greater detail, oxidized pyrimidines can be detected using the 
endonuclease III enzyme, whereas 8-OH guanine as well as other damaged purines can be detected by 
using the formamidopyrimidine DNA glycosylase (Fpg) enzyme [91]. 
 
3.2. The Micronucleus Test 
Micronucleus (MN) assays are one of the preferred methods for assessing chromosome damage for 
conventional chemicals, as they enable both chromosome breakage and chromosome loss to be 
measured reliably [93]. Since micronuclei can only be expressed in cells which undergo complete nuclear 
division, a version of the micronucleus test was developed that identifies cells which have undergone 
nuclear division by their binucleate appearance when blocked from performing cytokinesis (cell division) 
by cytochalasin-B, a microfilament-assembly inhibitor [93, 94]. The cytokinesis-block micronucleus 
(CBMN) assay enables better precision because it prevents the data obtained from being confounded by 
altered cell division kinetics due to, possible, cytotoxicity of tested agents or suboptimal cell culture 
conditions [95]. 
As discussed above, the standard MN assay (OECD Test Guideline No. 487) [96] often (but not always) 
employs cytochalasin B (CB) to detect micronucleus frequency in binucleate cells formed after mitosis. 
However, it is known that CB also inhibits endocytosis, and thus might prevent NM cellular uptake. 
Hence, a modified protocol needs to be used for testing NMs: incubating with NM before adding CB. 
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This example illustrates that, with certain precautions, standard tests for DNA and chromosome damage 
may be applied to NM [37, 62].  
 
3.3. The Ames Test 
This is a test for identifying mutagens by studying the frequency with which they cause mutations 
inducing production of an essential amino acid in bacterial colonies initially lacking the ability to 
synthesize this amino acid [64, 97]. Those bacterial colonies for which mutations occur, giving rise to the 
ability to produce the essential amino acid, are termed “revertant colonies” [97]. Typically, as 
recommended in OECD Test Guideline No. 471 [97], one or more strains of Salmonella (S. typhimurium) 
and/or Escherichia coli are used e.g. the S. typhimurium strains TA97a, TA98, TA100, TA102, TA1535 and 
TA1537 or the E. coli strain WP2u-vrA⁻referred to in Table 3. It can also be used with or without 
metabolic activation i.e. typically with or without “S9- mix” [97]. OECD Test Guideline No. 471 [97] 
recommends that a “positive” result for a single strain, with or without metabolic activation, should be 
identified based on identifying a concentration related increase in the number of revertant colonies 
and/or a reproducible increase at a single concentration. A “positive” Ames test result would then be 
assigned if a “positive” result was observed with any strain with or without metabolic activation.  It is 
widely used for the assessment of organic molecules, such as prospective pharmaceutical active 
ingredients [98], and there are considerable Ames test data for these chemicals in the public domain 
[99, 100]. However, it has been suggested that the Ames test is one of the least appropriate genotoxicity 
tests for NMs due to poor uptake of NMs by bacterial cells [37, 101]. 
 
3.4. Chromosome aberration  
Chromosome aberrations result from failures in repair processes such that breaks either do not rejoin or 
rejoin in abnormal configurations [102]. The purpose of the in vitro chromosomal aberration test is to 
identify agents that cause structural chromosome aberrations in cultured mammalian cells. 
However, it is considered sub-optimal, compared to the micronucleus test, as it substantially slower to 
perform and cannot detect the same kinds of chromosomal abnormalities i.e. it cannot detect aneugens 
as well as clastogens [37].
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Table 1. Current review of comet assay results on metal oxide/silica NMs (+positive; -negative; +/-equivocal). As explained in 
section 3, each row in this table summarizes all genotoxicity data found for this test for all nanomaterials with a given core 
chemical composition reported in a given publication. 
Nanomaterial  
core chemical 
composition 
Physical 
characteristics 
(size and etc) 
Cells Exposure Results Summary Reference 
Al2O3 
Two aluminium 
oxide NMs were 
studied. 
Nominal 
diameters: 30 
nm and 40 nm. 
TEM analysis: 
39.85 ± 31.33 
nm and 47.33 ± 
36.13nm. DLS 
analysis: 
average 
diameters 212.0 
and 226.1 nm in 
water. 
 
In vivo  female 
Wistar rat 
peripherial blood 
cells  
Three dose levels (via 
gavage): 500, 1000 and 
2000 mg/kg body 
weight. Whole blood 
was collected at  4, 24, 
48 and 72 h 
 
Results showed 
statistically significant 
increase in % Tail 
DNA at 1000 and 2000 
mg/kg dose levels after 4, 
24 and 48 h with both 
aluminium oxide NMs 
studied in comparison to 
the control group. 
 
+ [81] 
Al2O3 
Nominal size: 
16.7 nm. DLS 
analysis:  
hydrodynamic 
diameter 16.7 ± 
1.3 nm. 
In vitro human 
embryonic kidney 
(HEK293) and  
peripheral blood 
lymphocytes cells 
Three concentration 
levels: 1, 10, and 100 
μg/ml. Exposure 
duration: 3 h  
Results showed that all 
concentration levels of 
Al2O3 did not induce any 
marked genotoxicity 
 
- [103] 
Al2O3 
Nominal size < 
50 nm.  
In vitro mouse 
lymphoma 
(L5178Y) cells and 
human bronchial 
epithelial (BEAS-
Three concentration 
levels for L5178Y cells: 
1250, 2500, 5000 
µg/mL. Three 
concentration levels for 
 Al2O3 NM induced DNA 
damage in  L5178Y at 
1250 to 5000 μg/ml with 
S9 mix (+S9) and induced 
DNA damage at 2500 
+ [104] 
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2B) cells BEAS-2B cells: 68.36, 
136.72, 273.44 µg/mL 
(+S-9); 97.66, 195.32, 
390.63 µg/ml (-S-9). 
Exposure duration: 2 h 
μg/mL without S9 mix (-
S9). A significant increase 
in DNA tail was observed 
in  BEAS-2B cells at  all 
concentrations tested 
under both +S9 and -S9 
conditions. 
Bi2O3 
Nominal size 
between 90 and 
210 nm. 
In vitro Allium 
cepa root cells  
 
Five concentration 
levels: 12.5, 25, 50, 75, 
and 100 ppm. Exposure 
duration: 4 h 
Results showed a dose-
dependent increase in 
the DNA damage at all 
concentrations except 
12.5 ppm compared to 
negative control. 
+ [105] 
CeO2 
Nominal size < 
25 nm. TEM 
analysis: 25 ± 
1.512 nm. DLS 
analysis:   
hydrodynamic 
diameter 269.7 
± 27.398 nm 
In vitro human 
neuroblastoma 
(IMR32) cells 
Five concentration 
levels: 10, 20, 50, 100, 
and 200 mg/ml. 
Exposure duration: 24 h 
A significant increase in 
the percentage of tail 
DNA was observed only 
at the highest dose of 200 
mg/ml 
 
+ [106] 
CeO2 
Nominal size: 7 
nm. DLS 
analysis: 
hydrodynamic 
diameter 15 nm 
 
 
In vitro human 
dermal fibroblasts 
Seven concentration 
levels: 0.006, 0.06, 0.6, 
6, 60, 600, 1200 mg/l. 
Exposure duration: 2 h 
 
A dose-response increase 
in the olive tail moment 
at very low doses (0.006 
mg/l) was observed 
 
+ [107] 
CeO2 
TEM analysis: 
average size 5.5 
nm. XRD 
analysis: 6.3 nm 
 
In vitro human 
lens epithelial 
cells 
Two concentration 
levels: 5 and 10 μg/ml.  
Exposure duration: 24 h 
Results showed that 
nano-CeO2, at either 
tested dose, did not 
cause any damage to the 
DNA in cultured eye lens 
- [108] 
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epithelial cells. 
CeO2 
Nominal size < 
25 nm. TEM 
analysis: longest 
dimension 
between 4 and 
25 nm. DLS 
analysis: 225 
nm. 
 
In vitro human 
alveolar Type II-
like epithelial 
(A549) and 
bronchial 
epithelium 
(BEAS-2B) cells 
Two concentration 
levels: 40 and 80 μg/ml. 
Exposure duration: 4 h 
In A549 cells, CeO2 
significantly increased the 
amounts of DNA breaks 
compared to control 
group at both tested 
concentrations in a dose-
dependent manner. In 
BEAS-2B cells,  CeO2  
caused significantly 
increased levels of DNA 
breaks only at 80 μg/ml. 
+ [109] 
CeO2 
SEM analysis: 
average 
diameter 
between 16 and 
22 nm. 
 
In vitro human 
alveolar 
adenocarcinoma 
(A549),  
colorectal 
adenocarcinoma 
(CaCo2) and  
hepatic 
carcinoma 
(HepG2) cells 
Three concentration 
levels: 0.5, 50, 500 
μg/ml. Exposure 
duration: 24 h  
 + [110] 
CeO2 
Two different 
types of CeO2 
were studied. 
Nominal size: 30 
and 15 nm 
In vivo Daphnia 
magna and 
Chironomus 
riparius 
Single dose level: 1 
mg/l. Exposure 
duration: 24 h 
Tail and olive tail 
moments increased in 
both tested species  
+ [111] 
CeO2 
Nominal size: 3 
nm. DLS 
analysis: 
hydrodynamic 
diameter 350 
nm 
In vitro female 
mice oocytes and 
follicular cells 
Four concentration 
levels: 2, 5, 10 and 100 
mg/l. Exposure 
duration: 2 h 
A significant and dose-
dependent increase in 
DNA damage was shown 
in follicular cells exposed 
to CeO2 NMs at all 
concentration levels. In 
oocytes surrounded by 
+ [92] 
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zona pellucida, DNA 
damage was observed 
only at 10 and 100 mg/l 
Co3O4 
TEM analysis: 21 
nm. DLS 
analysis: 
average 
hydrodynamic 
size 264.8 nm 
(water) 
In vitro human 
hepatocarcinoma 
(HepG2) cells 
Three concentration 
levels: 5, 10 and 15 
µg/ml. Cells were 
treated for 24 and 48 h 
Cells exhibited a 
significant increase in 
DNA damage at almost all 
concentration levels, 
after 24 and 48 h, except 
for 5 µg/ml after 24 h. 
+ [112] 
Co3O4 
Nominal size < 
50 nm. TEM 
analysis: longest 
dimension 
between 9 and 
62 nm. DLS 
analysis: 222 
nm. 
 
In vitro human 
alveolar Type II-
like epithelial 
(A549) and 
bronchial 
epithelium 
(BEAS-2B) cells 
Two concentration 
levels: 40 and 80 μg/ml. 
Exposure duration: 4 h 
In A549 cells, Co3O4 
significantly increased the 
amounts of DNA breaks 
compared to control 
group only at 40 μg/ml. In 
BEAS-2B cells,  Co3O4 
caused significantly 
increased levels of DNA 
breaks only at 80 μg/ml. 
+ [109] 
CuO 
Nominal size: 28 
nm. SEM 
analysis: 
primary particle 
size 50 nm 
In vitro human 
lung type II 
epithelial  (A549) 
cells 
One concentration 
level: 80 μg/ml. 
Exposure duration: 4 h 
CuO NM showed 
significant levels of DNA 
damage at test conditions 
+ [113] 
CuO 
Nominal size: 42 
nm. TEM 
analysis: 
average size 
between 20 and 
40 nm. DLS 
analysis: 220 nm 
In vitro human 
lung type II 
epithelial  (A549) 
cells 
Three concentration 
levels: 2, 40 and 80 
μg/ml. Exposure 
duration: 4 h 
A significant increase in 
DNA damage was 
observed at 
concentrations of 40 and 
80 μg/ml 
+ [114] 
CuO 
Nominal size: 42 
nm. TEM 
In vitro human 
lung type II 
Two concentration 
levels: 40 and 80 μg/ml. 
A significant damage was 
found at 80 μg/ml. 
+ [31] 
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analysis: 
average size 
between 20 and 
40 nm. DLS 
analysis: 200 nm 
epithelial  (A549) 
cells 
Exposure duration: 4 h However, an increased 
(non-significant) DNA 
damage was also 
observed at 40 μg/ml 
CuO 
Four different 
CuO 
nanoparticles 
were studied, 
with the 
following size 
measurements 
and shapes 
determined by 
TEM: (1) 10-100 
nm (unspecified 
shape); (2) 7±1 
nm (spheres); 
(3) 7±1×40±10 
nm (rods); (4) 
1200±250×270±
50×30±10 nm 
(spindles) 
In vitro human 
murine 
macrophages 
RAW 264.7 cells 
and  peripheral 
blood 
lymphocytes 
(PBL). 
Three concentration 
levels: 0.1, 1 and 10 
μg/ml. Exposure 
duration: 2 and 24 h 
For RAW264.7 cells, all 
four tested nanoparticles 
caused statistically 
significant increase in 
primary DNA damage 
after 2 and 24h 
treatments at all 
concentrations. For PBL 
cells, statistically 
significant primary DNA 
damage was also 
detected for all tested 
CuO samples except for 
the following results: 
spheres (0.1  μg/mL , 24h; 
1  μg/mL, 2h) and 
spindles (0.1  μg/mL , 
24h; 0.1  μg/mL, 2h).   
+ [115] 
CuO 
Nominal size: 10 
nm. TEM 
analysis: size 
between 20 and 
40 nm. DLS 
analysis:  
hydrodynamic 
diameter 276.4 
nm (water) 
In vitro  human 
lung epithelial 
(A549) cells 
Two concentration 
levels: 5 and 15 mg/l. 
Exposure duration: 2, 4, 
8, 16 and 24 h 
 
A time-dependent 
increase in DNA damage 
was observed for the 15 
mg/l concentration level 
at 8, 16 and 24 h of 
exposure. For the 5 mg/l 
concentration level, a 
significant increase in 
DNA damage was shown 
only at 24 h of exposure 
+ [116] 
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CuO 
SEM analysis: 
diameter 
ranging from 20 
to 200 nm. DLS 
analysis: 
average size 500 
± 20 nm after 
sonication 
In vitro rainbow 
trout (O. mykiss) 
red blood cells; in 
vivo rainbow 
trout (O. mykiss) 
erythrocytes 
In vitro: One 
concentration level = 
7.5 µg/ml; Exposure 
duration: 1 h. In vivo ( 
intraperitoneal 
injection): One dose 
level of CuO NM 
expressed in terms of 
the equivalent mass of 
Cu =  1 µg/g body 
weight. Exposure 
duration: 38 h 
The percentage of tail 
DNA significantly 
increased in the presence 
of Cu compared to the 
control only in the in vitro 
study 
+ [117] 
CuO 
Nominal size < 
50 nm. TEM 
analysis: 31 ± 10 
nm. DLS 
analysis: 284.0 ± 
21.2 nm 
In vivo Mytilus 
galloprovincialis 
hemolymph cells 
One dose level: 10 µg/l. 
Exposure duration: 3, 7 
and 15 days 
An increase both in the 
olive tail moment and in 
the percentage of tail 
DNA was observed 
following 7 days of 
exposure. 
+ [118] 
CuO 
Nominal size < 
100 nm. 
Hydrodynamic 
size of 204 nm 
 
In vivo Macoma 
balthica soft 
tissue cells 
One concentration level 
of CuO expressed in 
terms of the equivalent 
mass of Cu = 10 mg/l. 
Exposure duration: 35 
days 
No significant genotoxic 
effects were observed  
- [119] 
CuO 
Nominal size: 
10−100 nm. 
TEM analysis: 
29.5 nm. 
Hydrodynamic 
size: 197 nm 
(deionized 
water) and 810 
In vivo worms H. 
diversicolor 
coelomocytes 
cells and clams S. 
plana hemocytes 
cells 
One dose level: 10 µg/l. 
Exposure duration: 21 
days 
In both species, 
percentages of tail DNA 
were significantly 
increased 
+ [120] 
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nm (seawater) 
CuO 
Nominal size: < 
50 nm. DLS 
analysis: 1511 ± 
468 nm (water) 
3475 ± 357 nm 
(medium) 
 
In vitro S. 
cerevisiae cells 
One concentration 
level: 31.25 mg/l. No 
information about 
exposure duration 
Cells exposed to CuO 
NMs showed a significant 
amount of DNA damage 
compared to control. 
+ [121] 
CuO 
Nominal 
average particle 
size: 50 nm. 
TEM analysis: 
55.80 ± 8.70 
nm. DLS 
analysis: 68.5 ± 
5 nm 
In vitro human 
skin epidermal 
(HaCaT) cells 
Three concentration 
levels: 5, 10 and 20 
mg/ml. Cells were 
treated for 24 and 48 h 
A significantly high DNA 
damage in treated cells 
was observed 
+ [122] 
Fe2O3 
TEM analysis: 35 
± 14 nm. DLS 
analysis:  Z-
average 
hydrodynamic 
diameter 900 
nm 
In vitro Syrian 
hamster embryo 
(SHE) cells 
Three concentration 
levels: 10, 25 and 50 
μg/cm2. Cells were 
treated for 24 h 
No significant DNA 
damage was found with   
Fe2O3 particles, at any of 
the tested concentrations 
- [123] 
Fe2O3 
Nominal size: 90 
nm. TEM 
analysis: 
average particle 
diameter 93 
nm. DLS 
analysis: 
In vitro human 
lung epithelial 
cells (A549) and 
murine alveolar 
macrophages 
(MH-S) 
One concentration 
level: 40 μg/cm2. 
Exposure duration: 24 h 
Tail DNA was not 
modified following 
incubation with  Fe2O3 
NM 
- [124] 
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average particle 
hydrodynamic 
diameter 68 nm 
Fe2O3 
Nominal size < 
100 nm. DLS 
analysis: 
hydrodynamic 
diameter 50 nm 
In vitro human 
lung fibroblasts 
(IMR-90) and 
human bronchial 
epithelial cells 
(BEAS-2B) 
Four concentration 
levels: 2, 5, 10, 50 
μg/cm2. Exposure 
duration: 24 h 
DNA damage was showed 
at concentrations of 10 
and 50 μg/cm2 in IMR-90 
cells and  at 50 μg/cm2 in 
BEAS-2B cells  
+ [125] 
Fe2O3 
Nominal size: 29 
nm. TEM 
analysis: 
average size 
between 30 and 
60 nm. DLS 
analysis: 1580 
nm. 
In vitro human 
lung type II 
epithelial  (A549) 
cells 
Three concentration 
levels: 2, 40 and 80 
μg/ml. Exposure 
duration: 4 h  
No significant DNA 
damage was observed at 
tested concentration 
levels 
- [114] 
Fe2O3 
Nominal size: 29 
nm. TEM 
analysis: 
average size 
between 30 and 
60 nm. DLS 
analysis: 1.6 
μm. 
 
In vitro human 
lung type II 
epithelial  (A549) 
cells 
Two concentration 
levels: 40 and 80 μg/ml. 
Exposure duration: 4 h 
No significant DNA 
damage was showed at 
tested concentration 
levels 
- [31] 
Fe2O3 
Nominal size 
 < 50 nm. TEM 
analysis: mean 
size 29.75 ± 1.87 
nm. DLS 
analysis: 
hydrodynamic 
In vivo albino 
Wistar female rat 
peripherial blood 
cells   
Three dose levels (oral 
administration): 500, 
1000 and 2000 mg/kg 
body weight. Exposure 
duration: 6, 24, 48 and 
72 h 
No statistically significant 
damage was observed at 
any sampling time in 
comparison to control. 
- [126] 
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diameter 363 
nm (water) 
Fe2O3 
Nominal mean 
size: 6 nm.  TEM 
and XRD mean 
analysis 
coherent 
diameter: 6 nm.  
In vitro human 
fibroblast cells 
Six concentration levels: 
0.001, 0.01, 0.1, 1, 10 
and 100 μg/ml. 
Exposure duration: 2 
and 24 h 
No DNA damage was 
observed at any tested 
concentration levels 
- [127] 
Fe2O3 
Nominal size < 
50 nm. TEM 
analysis: 29.75 ± 
1.87 nm. DLS 
analysis: 363 nm 
In vivo female 
Wistar rats 
peripheral blood 
leucocytes 
Three dose levels (oral 
administration): 500, 
1000 and 2000 mg/kg 
body weight. Exposure 
duration: 6, 24, 48 and 
72 h 
No statistically significant 
damage was observed at 
6, 24, 48, 72 h sampling 
time in comparison to 
control 
- 
 
[128] 
Fe3O4 
 TEM analysis: 
average 
diameter 10 nm 
(naked 
particles) 
increased up to 
150 nm upon 
surface 
modifications 
In vitro murine 
fibroblast cell line 
(L-929 cells from 
mouse 
subcutaneous 
connective tissue) 
Three concentration 
levels: 100, 200 and 
1000 ppm. Exposure 
duration: 24 h 
NMs tested showed dose-
dependent genotoxic 
effects on the cells, which 
varied with surface 
modifications, although 
not all surface variations 
gave statistically 
significant results versus 
the non-treated control 
+ [129] 
Fe3O4 
TEM analysis: 27 
± 8 nm. DLS 
analysis: 
hydrodynamic 
diameter 
between 700 
and 800 nm 
In vitro Syrian 
hamster embryo 
(SHE) cells 
Three concentration 
levels: 10, 25 and 50 
μg/cm2. Cells were 
treated for 24h 
No significant DNA 
damage was found with 
iron oxide particles at any 
concentration level. 
- [123] 
Fe3O4 
TEM analysis: 
24.83 nm. DLS 
analysis: 
In vitro human 
skin epithelial 
Three concentration 
levels: 25, 50 and 100 
µg/ml. Cells were 
The cells exposed to 
different concentrations, 
exhibited significantly 
+ [130] 
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average 
hydrodynamic 
size was 247 nm 
(water) and 213 
nm (cell culture 
medium) 
(A431) cells treated for 24h higher DNA damage in 
cells than those of the 
controls. 
Fe3O4 
TEM analysis: 
24.83 nm. DLS 
analysis: 
average 
hydrodynamic 
size was 247 nm 
(water) and 213 
nm (cell culture 
medium) 
In vitro human 
lung epithelial 
(A549) cells 
Three concentration 
levels: 25, 50 and 100 
µg/ml.  Cells were 
treated for 24h 
The cells exposed to 
different concentrations, 
exhibited significantly 
higher DNA damage in 
cells than those of the 
controls. 
+ [130] 
Fe3O4 
Nominal size: 
from 20 nm to 
60 nm. Photon 
correlation 
spectroscopy 
(PCS) analysis: 
mean diameter 
of 311 nm 
In vitro human 
lung 
adenocarcinoma 
type-II alveolar 
epithelial cells 
A549 
Four dose levels: 1, 10, 
50 and 100 μg/cm2. 
Cells were exposed for 4 
h 
DNA damage was 
observed in a 
concentration-dependent 
manner 
+ [131] 
Fe3O4 
Nominal size: 29 
nm. TEM 
analysis: 
average sire 
between 30 and 
60 nm. DLS 
analysis: 1.6 μm 
In vitro human 
lung type II 
epithelial  (A549) 
cells 
Two concentration 
levels: 40 and 80 μg/ml. 
Exposure duration: 4 h 
No DNA damage was 
showed at the two tested 
concentration levels 
- [31] 
Fe3O4 
Nominal size 
between 20 and 
30 nm. TEM 
In vitro human 
lung type II 
epithelial  (A549) 
Three concentration 
levels: 2, 40 and 80 
μg/ml. Exposure 
No DNA damage was 
observed at the tested 
concentration levels 
- [114] 
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analysis: 
average size 
between 20 and 
40 nm. DLS 
analysis: 200 nm 
cells duration: 4 h 
Fe3O4 
TEM analysis:   
average size 8.0 
± 2.0 nm 
In vitro human  
embryonic kidney 
(HEK-293) and  
peripheral blood 
lymphocytes 
(HPL) cells   
Three concentration 
levels: 10, 30 and 70 
μg/ml. Exposure 
duration: 30 min and 1 
h 
A significant increase in 
DNA damage was 
observed at all tested 
concentrations after 1 h 
exposure with both types 
of cells 
+ 
[132] 
 
Fe3O4 
Nominal size: 30 
nm. TEM 
analysis: : 
longest 
dimension 
between 20 and 
40 nm. DLS: 200 
nm 
In vitro human 
alveolar Type II-
like epithelial 
(A549) and 
bronchial 
epithelium 
(BEAS-2B) cells 
Two concentration 
levels: 40 and 80 μg/ml. 
Exposure duration: 4 h 
Fe3O4  NM caused 
significant DNA damage 
only In BEAS-2B cells, at 
40 μg/ml 
 
 
+ [109] 
MgO 
Nominal size: 8 
nm 
 
In vitro human 
colon epithelium 
(CaCo-2) cells 
One concentration 
level: 20 mg/cm2. 
Exposure duration: 4 h 
No significant change 
compared to the control 
was observed. 
- [133] 
MnO2 
Nominal size: 45 
nm. TEM 
analysis: 45 ± 17 
nm. DLS 
analysis: 334.4 
nm. 
 
In vivo female 
albino Wistar rat 
peripherial blood 
leucocytes (PBL) 
Three dose levels: 100, 
500 and 1000 mg/kg 
body weight. Exposure 
duration: 6, 24, 48 and 
72 h 
A significant increase in 
the percentage of tail 
DNA was observed in the 
at the highest dose of 
1000 mg/kg body weight 
at 24 and 48 h sampling 
times; however, no 
significant DNA damage 
was observed at 6 and 
72 h. An increase in the 
percentage of tail DNA 
was observed after 
+ 
[128] 
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treatment with lower 
doses of 100 mg/kg body 
weight and 500 mg/kg 
body weight, but these 
results were not 
statistically significant at 
all-time intervals 
compared with the 
control groups. 
MnO2 
TEM average 
mean size 
diameter: 42.63 
± 23 nm. DLS 
size in water: 
324.8nm. (The 
result of DLS 
showed larger 
values than NPs 
size measured 
by TEM, 
indicating NPs 
formed larger 
agglomerates in 
water 
suspension. 
Surface area: 
52.21 m2/g.) 
 
In vivo wistar rat 
leucocytes and 
bone marrow 
cells 
After 28-day repeated 
oral dosing in male and 
female Wistar rats at 
various doses (30, 300, 
1000 mg/kg/body 
weight per day) for 28 
days. 
A statistically significant 
(P < 0.01) increase in the 
DNA damage (percentage 
oftail DNA) with the 
highest and medium 
doses. No significant 
increase was found with 
the lowest dose. 
+ 
 
[134] 
NiO 
Nominal size: 
<50 nm. TEM 
analysis:  2-67 
nm. DLS: 167 
nm. 
In vitro human 
alveolar type II 
like epithelial 
A549 and 
bronchial 
40-80 μg/mL for 4h 
In  A549 cells DNA in tail 
31.6% at 40 μg/mL 
increased amounts of 
DNA breaks, significantly 
increased at 80 μg/mL. In 
+ [109] 
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 epithelium BEAS-
2B cells 
BEAS-2B cells NiO (29.0%) 
at the low dose and 
28.5% at the higher dose. 
SiO2 
Nominal size: 15 
nm. TEM 
analysis:  11-27 
nm. DLS: 8.7 
nm. 
The particle size 
was calculated 
from the 
Brownian 
motion of the 
particles using 
the Stokes–
Einstein 
equation. 
 
In vitro human 
alveolar type II 
like epithelial 
A549 and 
bronchial 
epithelium BEAS-
2B cells 
40-80 μg/mL for 4h 
No significant change 
compared to the control 
was observed 
- [109] 
SiO2 
Two different 
types of SiO2 
were used; 
Nominal size: 10 
and 7 nm. BET 
surface area: 
644.44 and 
349.71 m2/g. 
In vivo in the 
freshwater 
crustacean 
Daphnia 
magna and the 
larva of the 
aquatic midge 
Chironomus 
riparius 
The fish were collected 
24 h from the control 
and experimental tanks 
after exposure to 1 
mg/L of NPs. 
No genotoxic effect on 
either species as no 
significant increase both 
in the tail and in the Olive 
Tail Moment was 
observed 
- [111] 
SiO2 (amorphous) 
Two silica NMs 
were tested. 
Nominal sizes: 
15 nm and 55 
nm. DLS 
analysis: z-
average particle 
In vivo Wistar rat 
peripheral blood 
cells 
Single dose for 15 nm 
SiO2: 50 mg/kg; two 
dose levels for 55 nm 
SiO2: 25 mg/kg and 125 
mg/kg. Rats injected i.v. 
at 48h, 24h, and 4h 
prior to tissue collection 
The percentage of DNA 
damage was 
increased compared to 
vehicle-treated rats by 
1.4–1.6-fold in all three 
tissues at the maximum 
tolerated dose (50 mg/kg) 
+ [82] 
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diameters (pH 
7.5): 31.6 nm 
and 105.1 nm 
 
of the 15 nm silica NPs, 
which was significant in 
the liver. 
SiO2 (with three 
types of 
functionalization:
unmodified,  
vinyl and 
aminopropyl 
groups 
SEM average 
diameter:  10 to 
50 nm. 
DLS average 
hydrodynamic 
diameter: 4 ± 
4.6, 176.7 ± 5.1 
and 256.3 ± 7.2 
nm 
respectively. 
In vitro human 
peripheral blood 
lymphocytes 
10, 25, 50 and 100 
µg/mL after 2 and 24 h 
Results revealed 
no significant increase of 
basal DNA strand breaks 
in cells treated with all 
three types of silica.  
 
- [135] 
SiO2 (amorphous, 
fumed) 
Nominal size: 14 
nm. BET surface 
area: 200 m2/g. 
 
In vitro human 
colon epithelium 
cell line (CaCo-2) 
Cells were treated 4h 
with 20 mg/cm2 
particles (in MEM 
without serum) 
FPG comet assay results 
found no significant 
effect in DNA strand 
breakage and slight 
effects in oxidative DNA 
damage study. 
- [133] 
SiO2 
Nominal 
diameter: 50 
nm 50 ± 3 nm. 
TMR- and 
RuBpy-doped 
luminescent 
silica NP 
(laboratory 
synthesised) 
 
In vitro A549 cells 
0.1–500 μg/mL in 
DMEM with serum for 
48 and 72 h 
Low genotoxicity was 
found in alkaline comet 
assay. Tail length was not 
significantly different 
from the control after 
48h. Results showed a 
slight increase in DNA 
single-strand breaks after 
72 h. The comet assay 
result was further verified 
using PFGE indicating no 
additional DNA damage 
as compared to the 
untreated control. 
- [136] 
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SiO2 
Size distribution 
measured with 
High 
Performance 
Particle Sizer 
(HPPS):  by 
volume 7.21 nm 
(100%); by 
intensity 
9.08 nm (71.4%) 
and 123.21 
(28.6%). 
In vitro WIL2-NS 
human B-cell 
lymphoblastoid 
cells 
60 and 120 μg/mL for 
24 h 
No significant levels of 
DNA tail percentage in 
alkaline comet assay 
- [137] 
SiO2 
TEM analysis: 
20.2 ± 6.4 nm 
In vitro primary 
mouse embryo 
fibroblasts 
(PMEF) 
5 and 10 μg/mL 
particles in DMEM for 
24 h 
 There were significant 
increases in tail length, 
percentage of DNA in tail, 
tail moment and Olive 
Tail Moment after PMEF 
cells were treated with at 
both examined 
concentrations (6.8% tail 
DNA, p < 0.05) in alkaline 
comet assay. 
+ [55] 
SiO2 
Particle size 
distribution in 
the suspension 
as measured by 
the high 
performance 
particle sizer (Z-
Average size): 
12.2 nm. 
in vitro WIL2-NS 
human B cell 
lymphoblastoid 
cell line 
0, 60, 120 μg/mL in 10h 
There is no significant 
increment in DNA 
damage observed when 
measured by the comet 
assay. 
- [138] 
SiO2 ( 
amorphous, 
alumina-coated 
Five different 
samples of 
nominal size: 
In vitro human 
lymphoblastoid 
fibroblasts (T3T-
4  and 40 μg/mL for 3, 6, 
and 24h 
In the comet assay, DNA 
damage of human cells 
was assessed via 
- [139] 
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with a positive 
charge) 
30–400 nm 
 
L1) measuring  tail length, 
percentage of  tail DNA, 
and Olive 
Tail Moment. There were 
no significant differences 
between the control and 
tested NM 
SiO2 
Nominal 
powder 
diameter: 10 
nm 
In vitro mouse 
lymphoma cell 
line (L5178Y 
thymidine kinase 
(tk)+/--3.7.2C 
cells) and human 
bronchial 
epithelial cells 
(BEAS-2B) 
Concentrations from 
629.88 μg/mL to 
2,519.53 μg/mL with S-9 
and from 610.36 μg/mL 
to 2,441.41 μg/mL 
without S-9 in L5178Y 
cells 
Nano-silica significantly 
induced DNA damage at 
all concentrations 
compared to control (P < 
0.05) 
+ [140] 
SiO2 
TEM analysis: 
16.4 ± 2.5 nm 
and 60.4 ± 8.3 
nm 
In vitro human 
lung carcinoma 
(A549) cells 
Two concentration 
levels: 46 and 60 µg/ml. 
Exposure duration: 15 
min and 4h 
Treatment with 16 nm or 
60 nm SiO2 showed no 
increase of DNA strand 
breaks after 15 min or 4 h 
as compared to the 
controls. 
- [141] 
SiO2 
Nominal size: 
15, 30, 100 nm. 
Hydrodynamic 
sizes in MEM 
suspension 
after 24 hour 
were 14.6 ± 0.3, 
20.4 ± 1.7, 169.2 
± 3.1 nm 
In vitro human 
epidermal 
keratinocyte 
(HaCaT) cells 
Three concentration 
levels: 2.5, 5 and 10 
µg/ml.  Cells were 
treated for 24h 
Three SiO2 NMs caused 
more DNA damage and 
more percentage of DNA 
in the tail than untreated 
groups 
+ [142] 
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SiO2 
Nominal size: 12 
nm and 40 nm. 
TEM analysis: 
“12-nmNPs” 
ranged between 
16 and 40 nm; 
“40-nm NPs” 
varied between 
50 and 100 nm. 
DLS analysis 
(water): 165 nm 
(12-nm NP); 271 
nm (40-nm NP) 
In vitro human 
colon carcinoma 
cells (HT29) 
Seven concentration 
levels: 0.03, 0.3, 3.1, 
15.6, 31.3, 93.8, 156.3 
mg/cm2. Exposure 
duration: 3 and 24h 
After 3h as well as after 
24h of incubation, none 
of the tested particles 
really affected the 
integrity of the DNA of 
HT29 cells in the 
investigated 
concentration range. 
However, for some 
scattered concentration 
steps, significant 
differences compared 
with the medium control 
were apparent. The 
appearance of these 
significances seems to be 
more random and did not 
follow a recognisable 
trend 
- [143] 
SiO2 
Nominal size: 2-
5 nm. 
Agglomeration: 
1-5-μ granules. 
No further 
characterization 
reported in the 
paper 
In vivo 
F1(CBA×C57Bl/6) 
mice bone 
marrow and brain 
cells 
Two dose levels: 5 and 
50 mg/kg Exposure 
duration:  3, 24h and 7 
days 
A significant increase in 
the levels of DNA damage 
in the bone marrow cells 
of animals injected with 5 
mg/kg nc-Si was observed 
after 24h exposure. 
+ [144] 
SnO2 
No 
characterization 
of the NM is 
reported in the 
paper 
In vitro 
lymphocyte cells 
Two concentration 
levels: 50 and 100 
μg/mL. No exposure 
duration information 
No significant changes in 
the tail length were 
showed at both tested 
concentration levels 
- [145] 
TiO2 Nominal size: 25 In vitro murine Five dose levels: 10, 20, Results showed that TiO2 - [146] 
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nm. DLS 
analysis: mean 
particle size 300 
nm 
Manufacturer 
data: 
SEM analysis: 
aggregates. DLS 
analysis: 220 
nm. Ramon 
spectroscopy: a 
mixture of rutile 
and anastase 
forms. BET 
specific surface 
area: 27.1 m2/g. 
fibroblasts 
BALB/3T3 clone 
A31 
60, 100 and 250 μg/mL. 
Cells were exposed for 3 
and 24h 
NM caused only a slight 
(however with a clear 
concentration-effect 
relationship) genotoxic 
effect in BALB/3T3 
fibroblasts at the highest 
concentrations used. 
TiO2 
Nominal size: 21 
nm. DLS 
hydrodynamic 
diameter: 
129.50 ± 2.6 nm 
In vivo Adult male 
Wistar rats bone 
marrow cells 
Single dose of 5 mg/kg 
body weight. Animals 
were sacrificed at 24h, 1 
week and 4 weeks after 
the injections 
The values for exposed 
animals were sometimes 
slightly enhanced as 
compared to control, but 
results were not 
statistically significant 
- [147] 
TiO2 
Nominal size < 
25 nm. DLS  
hydrodynamic 
size (Z-average): 
1611 ± 21 nm 
after 24h 
In vivo P. 
mesopotamicus 
(pacu caranha) 
erythrocytes cells 
The fish were exposed 
(with visible light or 
ultraviolet and visible 
light) to the following 
concentrations of nano-
TiO2 during a 96 h 
period: 0 (control), 1, 
10, and 100 mg/l. 
No statistically significant 
differences between the 
groups were observed. 
- [148] 
TiO2 
Nominal 
average size: 75 
± 15 nm. 
ZetaSizer Nano 
In vitro chinese 
hamster lung 
fibroblasts (V79 
cells) 
Three dose levels: 5, 20 
and 100  μg/mL. 
Exposure duration: 6h 
and 24h 
However, TiO2 NPs 
exposure only increased 
the percentage of DNA in 
the tail (% Tail DNA) at 
- [149] 
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ZS90 
hydrodynamic 
diameter: 473.6 
nm and 486.8 
nm size when 
suspended in 
H2O and FBS-
free DMEM 
the concentration of 100 
μg/mL and at the time 
point 24h. 
 
TiO2 
Nominal size: 
2.3 nm. TEM 
analysis: 
average 
diameter  2.3 ± 
0.5 nm 
In vitro human 
embryonic kidney 
(HEK293) cells 
and  human 
peripheral blood 
lymphocytes 
Concentrations of 1, 10, 
or 100 μg/mL 
Results demonstrated 
that at all concentration 
NP did not induce any 
marked genotoxicity, 
except for 100 μg/mL. 
Produced significant 
genotoxicity and 
appeared more effective 
in the comet assay with 
and without the FPG and 
Endo III enzymes in both 
human peripheral blood 
lymphocytes and HEK293 
cell. In contrast ionic type 
did not show any positive 
result in the cells 
 
+ [103] 
TiO2 
Nominal size: 
<25 nm 
In vitro 
leukocytes from 
dolphins 
20, 50, and 100 μg/mL 
for 4, 24, and 48 h in 
RPMI with serum 
Positive in alkaline comet 
assay at 24 and 48 h 
+ [150] 
TiO2 
Nominal size: 
<100 nm. BET 
surface area: 
49.71 ± 0.19 
m2/g. DLS 
average particle 
Human lung 
fibroblasts (IMR-
90) and human 
bronchial 
epithelial cells 
(BEAS-2B) 
Concentrations of 2, 5, 
10, 50 μg/cm2 for 24 h 
in MEM with serum and 
in keratinocyte serum- 
free medium, 
respectively. 
TiO2-NPs did not induce 
DNA-breakage measured 
by the comet-assay in 
both human cell lines. 
+ [125] 
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hydrodynamic 
diameter: 91 
nm. 
TiO2 
Nominal size: 
20-50 nm. 
Particles were 
extracted from 
sunscreens. The 
precise 
composition of 
the samples 
(particle size, 
surface area per 
unit weight, 
presence/absen
ce of coatings). 
In vitro MRC-5 
fibroblasts with 
or without 
irradiation from a 
solar simulator 
0.025% w/v particles 
Positive in alkaline comet 
assay after combined 
treatment with sunscreen 
extract and irradiation. 
+ [151] 
TiO2 
Two crystalline 
forms (phases) 
of TiO2. Nominal 
size:  nanosized 
rutile (>95%, 
<5% amorphous 
SiO2 coating; 10 
× 40 nm), 
nanosized 
anatase (99.7%; 
size <25 nm).  
BET analysis: 
rutile 132 and  
anastase 222 
m2/g. The 
particles were 
also 
characterized by 
In vitro human 
bronchial 
epithelial cell line 
(BEAS-2B) 
Eight doses of 3.8-380 
μg/mL for 24, 48, or 72 
h 
In alkaline comet assay 
results showed induction 
of DNA damage by all the 
TiO2 forms examined, 
with SiO2-coated 
nanosized rutile having 
the lowest effects. 
Anatase was more active 
than (coated) rutile. 
+ [152] 
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TEM and XRD. 
TiO2 
TEM analysis: 
TiO2 particles 
consisted of 
agglomerates of 
10–60 nm 
crystallites with 
an average 
primary particle 
size of 21 nm. 
XRD analyses: 
the particles 
comprised of 
two phases of 
TiO2, anatase 
(74%, v/v) and 
brookite (26%, 
v/v), with 
respective 
crystallite sizes 
of 41 nm and 
7 nm. 
In vivo alveolar 
type II/Clara cells 
collected 
immediately after 
the last exposure 
of male C57BL/6J 
mice. 
 
The mice were exposed 
repeatedly, 4 h per day 
during 5 consecutive 
days, to three different 
concentrations of 
nanosized TiO2 (0.8, 7.2 
and 28.5 mg/m3). 
No significant induction 
of DNA damage was seen 
in the comet assay at any 
of the three doses of 
nanosized TiO2, when the 
exposed mice were 
compared with the 
corresponding negative 
controls. However, the 
ethylene oxide-treated 
mice (the positive control 
group) showed a 
statistically significant 
1.7-fold increase in the 
mean percentage of DNA 
in tail in comparison with 
the concurrent negative 
control group, despite the 
high inter-individual 
variation in DNA damage 
levels seen in the 
concurrent control 
animals. 
- [153] 
TiO2 
Nominal 
diameter: 5 nm. 
TEM primary 
particle size:4.9 
nm. BET surface 
area: 316 m2/g. 
DLS analysis: 
19.0 (13.5–31.3) 
(Anastase form) 
In vivo lung cells 
of rat (after a 
single or repeated 
intratracheal 
instillation in rats) 
The NPs were instilled 
intratracheally at a 
dosage of 1.0 or 
5.0mg/kg body weight 
(single instillation 
group) and 0.2 or 1.0 
mg/kg body weight 
once a week for 5weeks 
(repeated instillation 
group) into male 
In the comet assay, there 
was no increase in % tail 
DNA in any of the  TiO2 
groups. In the EMS group, 
there was a significant 
increase in % tail DNA 
compared with the 
negative control group. 
TiO2 NPs in the anatase 
crystal phase are not 
- [85] 
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Sprague-Dawley rats. A 
positive control, ethyl 
methanesulfonate 
(EMS) at 500mg/kg, was 
administered orally 3h 
prior to dissection. 
genotoxic following 
intratracheal instillation 
in rats. 
TiO2 
The UV-Titan 
L181 (NanoTiO2) 
was a rutile 
coated with Si, 
Al, Zr and 
polyalcohol.  
The average 
crystallite size 
was determined 
to be 20.6 nm 
and the powder 
had a specific 
surface area of 
107.7 m2/g. 
In vivo 
broncheoalveolar 
lavage cells of 
mice 
Mice received a single 
intratracheal instillation 
of 18, 54 and 162 μg of 
NanoTiO 2or 54, 162 
and 486 μg of the 
sanding dust from paint 
with and without 
NanoTiO 2 (evaluated 1, 
3 and 28 days after 
intratracheal 
instillation). 
Pulmonary inflammation 
and DNA damage and 
hepatic histopathology 
were not changed in mice 
instilled with sanding dust 
from Nano TiO2 paint 
compared to paint 
without Nano TiO2. 
- [154] 
TiO2 
Nominal size: 
20-80 nm. BET 
surface area: 50 
m2/g 
(mixture of 
anatase and 
rutile) 
In vitro human 
colon epithelium 
cell line (CaCo-2) 
Cells were treated 4h 
with 20 mg/cm2 
particles (in MEM 
without serum) 
No significant change 
comparing to the control 
in FPG-modified comet 
assay was observed. 
+ [133] 
TiO2 
SEM analysis: 
40–70 nm. 
(anastase form) 
In vitro 
lymphocytes and 
sperm cells 
4concentration levels:  
3.73, 14.92, 29.85 and 
59.7 µg/ml in PBS for 30 
min in the dark, 
preirradiated and 
simultaneous irradiation 
with UV 
Positive in alkaline comet 
assay with both cell 
types. 
The ZnO particles are 
capable of inducing 
genotoxic effects on 
human sperm and 
+ [155] 
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lymphocytes Stronger 
effects with TiO2 in 
lymphocytes with UV 
treatment. 
TiO2 
Nominal size: 7 
nm (NM 101), 
10 nm (NRCWE 
001, NRCWE 
002, NRCWE 
003) and 94 nm 
(NRCWE 004). 
TEM analysis: 4-
8/50-100 nm, 
80-400 nm and 
1-4/10-
100/100-
200/1000-2000 
nm. DLS analysis 
(MEM):  185, 
742 nm; 203-
1487 nm; 339 
nm 
In vitro human 
hepatoblastoma 
C3A cells 
Three concentration 
levels: 5, 10 and 20 
µg/cm2 or 2.5, 5 and 10 
µg/cm2.Exposure 
duration: 4h 
DNA damage was most 
evident following 
exposure to NM 101 
(TiO2 - 7 nm) and NRCWE 
002 (TiO2 - 10 nm 
positively charged). 
NRCWE 003 – negatively 
charged TiO2 10 nm is the 
only exception. 
+ [156] 
TiO2 
Nominal size: 12 
nm, 20 nm, 25 
nm. TEM 
analysis: 12 nm, 
21 nm, 24 nm 
In vitro A549 
human lung 
carcinoma cells 
(CCL-185) 
One concentration 
level: 100 µg/ml. 
Exposure duration: 4h, 
24h, 48h 
After 4h of exposure a 
significant increase in the 
level of DNA breaks was 
observed. This increase in 
the level of breaks further 
increased after 24h of 
exposure. 
+ [157] 
TiO2 
Nominal size: 17 
nm. No further 
characterization 
reported in the 
In vivo nulliparous 
time-mated mice 
(C57BL/6BomTac) 
bronchoalveolar 
One dose level 
(inhalation during the 
gestational period): 42 
mg UV-Titan/m3. 
Inhalation of UV-Titan did 
not affect the levels of 
DNA strand breaks in BAL 
or liver cells in the non-
- [158] 
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paper lavage (BAL) and 
liver cells 
Exposure duration: 
1h/day X 11 days 
pregnant females and 
dams compared with 
their controls. Prenatal 
exposure to UV-titan did 
not affect the levels of 
DNA strand breaks in the 
livers of newborn or 
weaned offspring 
compared with their 
controls 
TiO2 
Nominal size: 
10-20 nm. No 
further 
characterization 
reported in the 
paper 
In vivo 
earthworm 
Eisenia fetida 
(Savigny, 1826) 
Four dose levels: 0.1, 
0.5, 1.0, 5.0 g/kg dry 
soil. Exposure duration: 
7 days 
Earthworms exhibited 
DNA damage when 
exposed to ZnO at 1 and 
5 g/kg.  At 5 g/kg the 
degrees of DNA damage 
were significant when 
compared to controls. 
+ [159] 
TiO2 
Nominal size: 
5.9 nm, 34.1 
nm, 15.5 nm, 1-
10 nm. DLS 
analysis: 460 
nm, 400 nm, 
420 nm, 600 nm 
In vitro Chinese 
hamster lung 
fibroblast (V79) 
cells 
One concentration 
level: 100 mg/l. 
Exposure duration: 24h 
The % Tail DNA and the 
OTM were increased by 
twofold in cells treated 
with 100 mg/l of non-
coated nano-TiO2 after 
24h. Cell viability was 
more than 40% after 
exposure to 100 mg/L of 
nano-TiO2 after 24h. 
+ [160] 
TiO2 
Nominal size: 25 
nm. TEM 
analysis: 15–30 
nm; 
agglomeration 
size: 285 ± 52 
In vitro primary 
human nasal 
epithelial cells 
Four concentration 
levels: 10, 25, 50 and 
100 µg/ml. Exposure 
duration: 24h 
No genotoxic effect could 
be shown for any of the 
tested concentrations of 
TiO2-NPs. 
- [161] 
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nm 
TiO2 
Nominal size < 
25 nm. TEM 
analysis: 285 ± 
52 nm 
In vitro human 
peripheral blood 
lymphocytes 
Four concentration 
levels: 20, 50, 100, and 
200 µg/ml. Exposure 
duration: 24h 
No evidence for 
genotoxicity could be 
shown for any of the 
tested concentrations of 
TiO2-NPs. 
- [162] 
TiO2 
TEM analysis: 14 
± 4 nm and 25 ± 
6 nm. DLS 
analysis was 
carried out (see 
reference) 
In vitro Syrian 
hamster embryo 
(SHE) cells 
Three concentration 
levels: 10, 25 and 50 
μg/cm2. Cells were 
treated for 24h 
At the highest particle 
concentration (50 
μg/cm2), all TiO2 particles 
except rutile NPs caused 
increased DNA damage 
after 24 h of exposure. 
+ [123] 
TiO2 
Nominal size: 
100 nm. AFM 
analysis: 90–110 
nm 
In vitro Allium 
cepa, Nicotiana 
tabacum root or 
leaf nuclei and 
human 
lymphocyte cells 
(Plants) five 
concentration levels: 2, 
4, 6, 8 and 10 mM. 
Exposure duration: 3, 6 
and 24 h. (Lymphocytes) 
eight concentration 
levels: 0.25, 0.50, 0.75, 
1, 1.25, 1.50, 1.75, 2 
mM. Exposure duration: 
3 h 
 
A uniform pattern of dose 
response was observed in 
A. cepa at all treatment 
schedules, no particular 
time dependent effect 
was noticed. Similarly 
TiO2 NPs treated (24h) N. 
tabacum leaf nuclei 
showed an initial increase 
in extent of DNA damage 
followed by a gradual 
decrease up to the 
highest dose. The value 
was statistically 
significant at 2 mM. The 
percentage of tail DNA (% 
tail DNA) in lymphocytes 
treated with different 
concentrations of NPs 
revealed a distinct 
+ [163] 
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pattern of genotoxicity. 
These NPs showed signs 
of significant DNA 
damage only at lower 
concentration (0.25 mM) 
followed by gradual 
decrease 
TiO2 
Nominal size: 
~100 nm. TEM 
analysis: 50.93 ± 
7.08 nm. DLS 
analysis: 
average 
hydrodynamic 
diameter 
6180.73 nm 
In vitro human 
lymphocyte cells 
Three concentration 
levels: 25, 50 and 100 
µg/ml. Exposure 
duration: 3 h 
DNA fragmentation 
induced by TiO2 NPs in 
human lymphocytes was 
statistically significant at 
a treatment dose of 25 
mg/ml. Treatment doses 
of 50 and 100 mg/ml 
induced DNA damage, 
but was not significant 
compared with the 
control set 
+ [164] 
TiO2 
Nominal size: 21 
nm and 50 nm. 
DLS analysis: 21 
± 0.8 nm for 
nano-TiO2 (21 
nm) and 50 ± 
0.5 nm for 
nano-TiO2 (50 
nm) 
In vitro Allium 
cepa root 
meristem cells 
Three concentration 
levels: 10,100 and 1000 
µg/ml. Exposure 
duration: 1h 
The results obtained from 
root meristem cells of A. 
cepa demonstrated that 
only the highest 
concentration (1000 
μg/mL) of TiO2 NPs (21 
nm) was statistically 
significant in comparison 
to the control, while all 
concentrations of TiO2 
NPs (50 nm) were 
significant for % DNA tail. 
On the other hand, TiO2 
NPs tested did show a 
dose-dependent 
+ [165] 
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increment for tail 
moment. 
TiO2 
Nominal 
average 
diameter 21 
nm. TEM 
analysis 24 ± 4.6 
nm (fresh); aged 
nTiO2 formed 
aggregates 
of particles with 
average 
diameters 
ranging from 
27.60 ± 
6.9 to 108.40 ± 
5.2 nm 
In vivo marine 
mussels (Mytilus 
galloprovincialis) 
haemocytes 
One dose level: 10 mg/l. 
Exposure duration: 4 
days 
All treatments showed 
significantly higher DNA 
damage than controls. 
Interestingly all TiO2 
treatments resulted in 
approximately 40% tail 
DNA and there were no 
significant differences 
between the treatments. 
+ [166] 
TiO2 
Nominal size: 21 
nm and <25 nm. 
DLS analysis: 
mean 
hydrodynamic 
diameter 160.5 
nm and 420.7 
nm 
In vitro human 
gastric epithelial 
cancer (AGS) 
One concentration 
level: 150 µg/ml. 
Exposure duration: 3h 
In the comet assay, there 
was a 1.88-fold significant 
increase in %Tail DNA 
when the cells were 
treated with TiO2 NPs. 
 
+ [167] 
TiO2 
Nominal size: 1–
3 nm. DLS 
analysis: 99.20 ± 
6.2 nm (water) 
337e5 ± 190e5 
In vitro S. 
cerevisiae cells 
One concentration 
level: 31.25 mg/l. No 
information about time 
exposure 
A significant amount of 
DNA damage was 
detected in NP-exposed 
cells when compared 
with controls. 
+ [121] 
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nm (medium) 
 
TiO2 
TEM analysis: 12 
±3 nm. BET 
analysis: 17 nm 
In vitro NRK-52E 
rat kidney 
proximal cells 
Four concentration 
levels: 50, 75, 100, 200 
µg/ml. Exposure 
duration: 24h 
DNA damage induced by 
TiO2-CEA increased with 
exposure concentration 
and was statistically 
significant for exposure 
concentrations equal or 
higher than 100 µg/ml. 
+ [168] 
TiO2 
TiO2 at 10 nm 
(Hombikat 
UV100) and 20 
nm (Millenium 
PC500) in 
diameter. No 
further 
investigations 
are reported in 
the paper. 
(Anatase form) 
In vitro human 
bronchial 
epithelial cells, 
BEAS-2B (ATCC 
CRL-9609) 
Cells were treated with 
10 μg/mL of TiO2 for 24 
h 
The results showed that 
apparent DNA damage 
was detected in 
treatment with 10 μg/mL 
anatase 10 nm particles 
+ [169] 
TiO2 
Nominal size: 25 
nm. X-ray 
diffraction 
analysis (XPD) 
analysis specific 
surface area: 50 
m2/g,  mean 
powder size 
approximately 
30 nm. 
 
(A mixture of 
In vitro human 
peripheral blood 
lymphocytes 
 
 
20, 50, or 100 μg/mL for 
6, 12, or 24 h 
Positive in alkaline comet 
assay. Reduced effect was 
found when cells were 
pretreated with N-
acetylcysteine. 
The dose- and time- 
dependent effect on DNA 
fragmentation was found. 
Lymphocytes exposed 
had a significantly greater 
OTM than those not 
exposed (P < 0.05). 
+ [170] 
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anatase (70–
85%) and rutile 
(30–15%)) 
 
TiO2 
Nanopowder 
nominal size: 63 
nm. TEM 
analysis: 20-100 
nm. DLS 
analysis: 300 
nm. 
 
In vitro A549 cells 
1 μg/cm2 (2 μg/mL), 20 
μg/cm2 (40 μg/mL), and 
40 μg/cm2 (80 μg/mL) 
for 4 h. FPG sensitive 
sites were measured at 
20 μg/cm2, and 40 
μg/cm2 after 4h. 
A dose-response trend in 
induced DNA damage 
could be seen in cells 
treated with TiO2. 
Positive in alkaline comet 
assay. In FPG particles 
caused a slight increase, 
although this was not 
statistically significant 
(19% tail, p < 0.001). 
+ [114] 
TiO2 
Nominal 
average size: 5 
nm. (anatase 
form) 
Fish skin cells 
1, 10, and 100 μg/mL 
for 2 or 24 h in cell 
medium with serum 
A modified comet assay 
using bacterial lesion-
specific repair 
endonucleases (Endo-III, 
FPG) was employed to 
specifically target 
oxidative DNA damage. 
Negative with 
endonuclease III. 
For the comet assay, 
doses of 1, 10 and 100 
g/mL in the absence of 
UVA caused elevated 
levels of FPG-sensitive 
sites, indicating the 
oxidation of purine DNA 
bases (i.e. guanine) by 
TiO2. UVA irradiation of 
TiO2-treated cells caused 
further increases in DNA 
+ [171] 
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damage. 
TiO2 
Mixture of 
anatase (25%) 
and rutile (75%). 
TEM cross 
sectional 
diameter Mean 
size: 24.4 ± 0.5 
nm, minimum = 
11.8 nm, 
maximum = 
38.5 nm). 
Though ENPs 
(sonicated in 
H2O) 
aggregated 
while preparing 
for TEM studies, 
the NPs could 
still be 
characterised as 
less than <100 
nm in diameter. 
In vivo rainbow 
trout gonad (RTG-
2) cells 
(fibroblastic cell 
line) 
5 and 50 μg/mL in MEM 
or PBS for 4 or 24 h with 
or without 30 min 
exposure to UV light 
Positive in alkaline and 
FPG comet assay in 
combination with UV. 
+ [172] 
TiO2 
Nominal size 
powder: 63 nm. 
TEM analysis: 
20-100 nm. DLS 
analysis: 300 
nm. 
In vitro A549 cells 40 to 80 μg/mL for 4h 
In alkaline comet assay 
significantly higher levels 
of DNA damage were 
found compared to 
control (24% tail, p < 
0.001). 
In FPG-modified comet 
assay, no significant levels 
of oxidative DNA damage 
at 80 μg/mL was found 
compared to control 
+ [31] 
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were observed. 
None of the particles 
caused a significant 
increase in oxidative DNA 
damage when cells were 
exposed to 40 μg/mL. 
TiO2 
HPPS size: by 
volume 6.57 nm 
(100%); by 
intensity: 8.2 
nm (80.4%) and 
196.52 nm 
(19.4%) 
In vitro WIL2-NS 
human B-cell 
lympho- blastoid 
cells 
WIL2-NS cells were 
incubated for 6, 24 and 
48 h with 0, 26, 65 and 
130  μg/mL. Results of 
comet assay were 
reported for 65 μg/mL 
for 24 h. 
There was a 3-fold 
significant 
(P < 0.05) increase in 
%Tail DNA when the cells 
were treated with UF-
TiO2 at a dose of 65g/mL 
for 24 h exposure (16±3% 
tail). 
+ [173] 
TiO2 
TEM dry size 
distribution: 
10x30 nm (They 
were heavily 
aggregated not 
only in dry 
powder but also 
in solutions 
(the aggregated 
sizes was 
approximately 
130–170 nm); 
(anastase form) 
In vitro TK6 
human 
lymphoblastoid 
cells 
 50, 100, 150, 200 
μg/mL for 24 h 
The standard comet assay 
and endonucleases 
enzyme-modified comet 
assay were performed. 
None of the TiO2-NPs 
treatments increased 
DNA damage in either of 
the assays. 
- [174] 
TiO2 
TEM primary 
particle size: 21 
nm. BET specific 
surface area: 50 
± 15 m2/g. DLS 
agglomerates 
range: 21-1446 
In vivo mice 
peripheral blood 
was collected by 
submandibular 
vein puncture 
60, 120, 300, and 600 
μg/mL concentrations in 
drinking water for 5 
days 
Tail moment significantly 
increased after TiO2 NPs 
treatment. The average 
tail moment was 0.0102 ± 
0.001 before treatment 
and 0.0137 ± 0.0011 after 
TiO2 NPs treatment. 
+ [89] 
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nm and mean 
size: 160 ± 5 
nm. 
(A mixture of 
75% anatase 
and 25% rutile 
TiO2, purity was 
at least 99.5% 
TiO2) 
TiO2 
TEM mean size: 
33.2 ± 16.7 nm. 
DLS analysis: 
(anastase form) 
In vivo  CBAB6F1 
mice,  brain, liver 
and bone marrow 
40, 200 mg/kg body 
weight, daily oral for 
seven days 
Increased DNA strand 
breaks in bone marrow 
cells was found. The % 
tail DNA in the comet tail 
significantly increased 
after treatment, from 
3.66 in the control group 
to 7.99  ± 1.21 and 6.8  ±  
1.13 in the treated groups 
(p < 0.05). No statistically 
significant changes have 
been found in the cells of 
liver and brain. 
+ [87] 
TiO2 
Nominal mean 
diameter: 
28nm. DLS  size 
of particles and 
agglomerates in 
cell culture 
medium 
analysis: 280 
nm. 
In vitro human 
lung epithelial 
A549 cells 
0, 5, and 15 μg/mL for 
12 h 
Alkaline comet assay, no 
change has been found 
comparing to the control. 
- [175] 
TiO2 
TEM size: 50 
nm. DLS mean 
hydrodynamic 
In vitro human 
epidermal cells 
(A431) 
Concentrations ranging 
form 80 to 0.008 μg/mL 
(0.008, 0.08, 0.8, 8, 80 
A statistically significant 
(p < 0.05) induction in the 
DNA damage was 
+ 
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size (in water): 
124.9 nm. 
μg/mL) observed by the FPG-
modified comet assay in 
cells exposed to 
0.8 μg/mL NPs 
(2.20 ± 0.26 vs. control 
1.24 ± 0.04) and higher 
concentrations for 6 h. 
TiO2 
TEM size: 30-70 
nm. DLS mean 
hydrodynamic 
size (in water 
and medium 
respectively): 
124.9-192.5 nm 
In vitro human 
liver cells (HepG2) 
1, 10, 20, 40 and 80 
µg/mL after 6h 
The FPG-modified comet 
assay revealed a 
significant (p < 0.05) 
concentration-dependent 
increase in oxidative DNA 
damage in response to 
TiO2 NP exposure as 
analysed using qualitative 
and quantitative 
parameters of the comet 
assay viz. OTM and % Tail 
DNA respectively. 
FPG elicited a significantly 
greater response at all 
the concentrations of 
TiO2 NPs 
 
+ 
 
[177] 
TiO2 
Two samples of  
TiO2: A1 and A2. 
XRD crystal 
form analysis: 
respectively 
anastase and 
mixture 
anastase:rutile 
2:8 ratio. SEM 
diameter: 
In vitro 
Erythrocytes 
4.8 μg/mL for 1h 
To investigate the 
presence of DNA damage 
due to oxidation of 
pyrimidine and purine 
bases, Endo III and FPG 
enzymes were used, 
respectively.  A 
statistically significant 
increase in the % tail DNA 
was observed in the 
+ [178] 
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spherical 10-20 
nm, spherical 
20-150 nm 
presence of A1 and A2 
TiO2 NPs when the slides 
were incubated with both 
enzymes. TiO2 NPs (4.8  
μg/mL) induce DNA 
damage and the entity of 
the damage is 
independent from the 
type (A1 or A2) of TiO2 
NPs used. 
TiO2 
TEM average 
particle size: 15 
nm. DLS average 
hydrodynamic 
radius: 820 nm. 
BET surface 
area: 190-290 
m2/g 
In vitro  and in 
vivo Tetrahymena 
thermophila  cells 
Two different 
concentrations (1 - 0.1 
µg/mL and 2 - 100 
µg/mL). Three different 
exposure scenarios 
(acellular, in vitro, in 
vivo) were applied and 
two different protocols 
of comet assay (alkaline 
lysis and  neutral lysis) 
After alkaline lysis 
indicated significant 
damage of DNA in 
T. thermophila in both in 
vivo and in vitro 
treatments. 
This was independent of 
the concentration of 
particles. 
Statistical analysis of 
comet assays by neutral 
lysis showed that in cells 
treated, the average DNA 
tail length 
does not significantly 
differ from that in control 
cells 
+ [179] 
TiO2 
XRD average 
size: 30.6 nm. 
DLS diameter in 
medium and 
water 
respectively: 
aggregates and 
In vitro human 
amnion epithelial 
(WISH) cells 
0.625, 1.25, 2.5, 5.0, 10, 
20 µg/kg for 6 h 
A significant induction (p 
< 0.05) in DNA damage (% 
DNA tail: 23.94 ± 0.66) at 
a concentration of 20 
µg/mL in neutral comet 
assay was observed 
+ [180] 
44 
 
particles of 13 
and 152 nm and 
in water 
aggregates of 
380 nm. 
(Crystalline 
polyhedral rutile 
synthesized for 
this study) 
TiO2 
Listed by the 
manufacturer: 
Primary particle 
size: 27.5 nm. 
Specific surface 
area: 49 m2/g.. 
DLS analysis of 
the NPs in 
different media 
is also reported. 
(Crystal form 
86% anastase 
and 14% rutile) 
In vitro human 
lung cells (BEAS-
2B) in three 
different 
dispersion media 
(KF, KB, and DM) 
Different 
concentrations from 0 
to 100 µg/mL for 24 h 
There was a 
concentration-dependent 
increase in DNA damage 
after TiO2 NP exposure in 
all three treatment media 
that was  genotoxic but 
statistically significant. 
All concentrations in all 
treatment media induced 
DNA damage that was 
significantly greater than 
the concurrent negative 
control except for two 
points: 10 μg/mL in KF 
and 50 μg/mL in DM 
+ [181] 
TiO2 
Listed by the 
manufacturer: 
Primary particle 
size: 27.5 nm. 
Specific surface 
area: 49 m2/g. 
DLS analysis of 
the NPs in 
different media 
is also reported. 
In vitro  human 
liver cells (HepG2) 
Different 
concentrations from 0 
to 100 µg/mL for 24h 
DNA damage increased 
significantly with 
increasing concentrations 
of nano-TiO2 in both 
treatment media, 
indicating a genotoxic 
effect. The responses at 
the two highest 
concentrations were 
significantly greater than 
+ [182] 
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(Crystal form 
86% anastase 
and 14% rutile.) 
the control; however, the 
type of medium used did 
not influence the level of 
DNA damage 
TiO2 
Listed by the 
manufacturer: 
Field-emission-
gun scanning 
electron 
microscopy 
(FEG-SEM) 
particle size 
within the 
agglomerates 
and aggregates 
TiO2-An and 
TiO2-Ru: <25 
and <100 nm. 
XRD analysis of 
crystal: TiO2-An 
anastase and 
TiO2-Ru rutile 
form. 
BET specific 
surface area: 
129.3 and 116.7 
m2/g 
In vitro human 
hepatic 
carcinoma cells 
(HepG2) 
Four concentration 
levels: 0, 1, 10, 100, 250 
µg/mL for 2, 4 and 24 h 
 
TiO2-An, but not TiO2-Ru, 
caused a persistent 
increase in DNA strand 
breaks (comet assay) and 
oxidized purines (FPG-
comet).  In HepG2 cells 
exposed to TiO2-An NPs 
we detected slight, 
however statistically 
significant (P < 0.05) 
greater amount of DNA 
strand breaks than in the 
control 
+ [183] 
TiO2 
Nominal size: 
<25 nm. BET 
specific surface 
area: 129.3 
m2/g. XRD 
analysis: 18 nm. 
FEG-SEM: 1 
HepG2 cells 
0, 1, 10, 100, 250 µg/mL 
for 2, 4 and 24 h 
 
UV pre-irradiated TiO2-B 
induced significant (p < 
0.05) increases in FPG-
sensitive sites after 2 h 
and 4 h exposure at all of 
the concentrations 
tested. 
+ [184] 
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TiO2 
Nanopowder 
nominal size: 
<25 nm. DLS 
mean 
hydrodynamic 
diameter: 
92±3.6 at 0h in 
the dispersion 
of 12.5 µg/mL. 
Allium cepa Root 
Tip 
When the roots reached 
2 to 3 cm in length they 
were treated with 
different concentrations 
(12.5, 25, 50, 100 
µg/mL) of TiO2 NP 
suspensions for 4 h 
The lowest reported 
exposure concentration 
of TiO2 NPs to exert a 
significant damage to 
DNA was 20 µg/mL. Olive 
Tail Moments of about 
2.3460.74 and 8.662.81% 
was observed at the test 
concentrations of 12.5 
µg/mL and 100 µg/mL 
respectively indicating 
damaged DNA structure 
+ [185] 
TiO2 
XRD analysis of 
different 
samples: 9, 10 
and 10 nm. 
(NM101,  
NRCWE001,  
NRCWE002,  
NRCWE003 that 
are in anatase 
form, 
respectively 
with no coating, 
no coating, 
positive charged 
and negative 
charged). 
TEM analysis 
respectively: 4-
8/50-100, 80-
400, 80-400 and 
80-400 nm) 
A  sample of 
In vitro HK-2 cells 
0.8, 40, 20, 60, and 40  
μg/cm2 after a 4h 
treatment 
Significant tail increase in 
FPG-modified comet for 
one of the samples of  
TiO2, others small but 
significant 
+ [186] 
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XRD size: 
approximately 
100 nm 
(NRCWE004). In 
this sample five 
different 
particle types 
were identified. 
 
TiO2 
Two different 
types of TiO2 
were used; 
Nominal size: 20 
and 7 nm. BET 
surface area: 
66.604 and 
300.81 m2/g 
In vivo in the 
freshwater 
crustacean 
Daphnia 
magna and the 
larva of the 
aquatic midge 
Chironomus 
riparius 
The fish were collected 
24 h from the control 
and experimental tanks 
after exposure to 
1 µg/L of NPs 
No genotoxic effect on 
either species as no 
significant increase 
in the tail/Olive Tail 
Moments was observed 
in these species when 
exposed 
- [111] 
V2O3 
Nominal size of 
spherical 
diameter: 
approximately 
70 nm. TEM 
average 
diameter: 25 
nm. TEM length: 
100 – 1.000 nm. 
(Needle-like 
structure) 
 
In vitro human 
epithelial lung cell 
line (A549) 
Concentrations: 1 and 
2 μg/cm2, time: 24, 36, 
48 h via inhalation 
Positive + [52] 
V2O5 
Nominal size of 
spherical 
diameter: 170 –
180 nm. 
In vitro human 
epithelial lung cell 
line (A549) 
Concentrations: 1 and 
2 μg/cm2, time: 24, 36, 
48 h via inhalation 
Negative - [52] 
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They are up to 
several hundred 
nanometer in 
length and 
usually have a 
diameter of less 
than 50 nm. 
(Rod-shaped) 
 
ZnO 
XRD analysis of 
different 
samples: 70 to > 
100 an 58-93 
nm. (NM110 
and NM111, 
with no 
coating,).  TEM 
size: 20-200/10-
450 and 20-
200/10-450 nm. 
BET surface 
area: 14 and 18 
m2/g. 
Mainly 2 
euhedral 
morphologies: 
1) aspect ratio 
close to 1; 2) 
ratio 2 to 7.5. 
Minor amounts 
of particles with 
irregular 
morphologies 
observed. 
In vitro HK-2 cells 
0.8, 40, 20, 60, and 40  
μg/cm2 after a 4h 
treatment 
No significant tail 
increase in % tail in FPG-
modified comet for one 
of the samples of ZnO, 
others small but 
significant 
+ [186] 
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M111 as M110 
but with 
different size 
distributions. 1) 
particles with 
aspect ratio 
close to 1; 2) 
particles with 
aspect ratio 2 to 
8. 
ZnO 
Two NPs of ZnO 
have been 
evaluated. EZ-1 
(coated) and EZ-
2 (uncoated) 
with the 
following 
characterization 
results 
respectively: 
TEM primary 
size: 30±20, 
40±20 nm. XRD 
powder 
hydrodynamic 
diameter in 
water: 70-150 
and 90-160 nm. 
In vitro A549, 
HT29, HaCaT cells 
0, 0.1, 1, 10 µg/mL for 
The results show a small, 
but significant increase in 
DNA damage compared 
to that of controls at 
concentrations of 10 
μg/mL ZnO for HT29 cells 
for the polymer coated 
NPs. For The HaCaT cells, 
only the polymer coated 
NPs (EZ-1) show an 
increase in DNA damage 
at 1 μg/mL, while the 
A549 cells are not 
significantly affected by 
any of the NPs. 
+ [187] 
ZnO 
Respectively 
Nominal size 
and  BET surface 
area: 10 nm, 70 
m2/g 
In vitro human 
colon epithelium 
cell line (CaCo-2) 
Cells were treated 4h 
with 20 µg/cm2 particles 
(in MEM without 
serum) 
Significant effects found 
in FPG-modified comet 
assay. 
+ [133] 
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(nanoactive 
aggregates) and 
20 nm, 50 m2/g 
(nanoscale 
particles). 
ZnO 
TEM mean size 
30 nm. DLS: 165 
nm. 
In vitro human 
epidermal cell 
line (A431) 
0.001, 0.008, 0.08, 0.8, 
5 μg/mL for 6h 
A significant induction (p 
< 0.05) in DNA damage 
was observed in cells 
exposed to ZnO NPs for 6 
h at 5 and 0.8 μg/mL 
concentrations compared 
to control. 
+ 
[188] 
 
ZnO 
TEM analysis: 
30, 50 and 70 
nm. DLS size in 
water: 272 nm. 
In vivo liver and 
kidney cells of 
mice after oral 
exposure 
50 and 300 mg/kg of 
NPs for 14 days 
In both alkaline and FPG-
modified comet assay, at 
the highest concentration 
DNA % tail was 
significantly increased 
(16.15±1.56) 
 
+ [189] 
ZnO 
TEM analysis: 30 
nm. DLS 
hydrodynamic 
size in water: 
165 nm. 
In vitro  A431 
cells 
Cells were exposed to 
0.001, 0.008, 0.08, 0.8, 
5 μg/mL for 6 h 
A significant induction (p 
< 0.05) in DNA damage 
was observed in cells 
exposed to ZnO NPs for 6 
h at 5 and 0.8 μg/mL 
concentrations compared 
to control respectively % 
DNA tail were 10.6 ± 0.76 
and 13 ± 1.5. 
+ [188] 
ZnO 
Respectively 
Nominal size 
and  BET: 50 
and 70 nm. TEM 
average size: 30 
nm. DLS mean 
hydrodynamic 
In vivo mice liver 
and kidney cells 
50 and 300 mg/kg mice 
oral exposure for 14 
consecutive days 
A statistically significant 
(p < 0.05) qualitative and 
quantitative 
increase in the oxidative 
DNA damage was 
observed in the liver of 
mice exposed to the 
+/- [189] 
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diameter 
(water): 272 
nm. 
higher dose (300 mg/kg) 
in the presence of FPG. 
However, no significant 
DNA damage was 
observed in the mice 
administered with the 
lower dose (50 mg/kg). 
There was no significant 
difference in the comet 
parameters in the kidney 
cells of control and ZnO 
NPs exposed mice. 
ZnO 
TEM analysis:  
20.2 ± 6.4 nm 
In vitro primary 
mouse embryo 
fibroblasts 
(PMEF) 
5 and 10 μg/mL 
particles in DMEM for 
24 h 
There were significant 
increases in tail length, 
percentage of DNA in tail, 
tail moment and Olive 
Tail Moment after PMEF 
cells were treated with at 
both examined 
concentrations (18.8% tail 
DNA , p < 0.01) in alkaline 
comet assay. 
+ [55] 
ZnO 
Nanopowder 
nominal size: 71 
nm. TEM 
analysis: 20-200 
nm. DLS 
analysis: 320 
nm. 
In vitro A549 cells 
1 μg/cm2 (2 μg/mL), 20 
μg/cm2 (40 μg/mL), and 
40 μg/cm2 (80 μg/mL) 
for 4 h. FPG sensitive 
sites were measured at 
20 μg/cm2, and 40 
μg/cm2 after 4h. 
DNA damage was induced 
when cells were exposed 
for 4 h to 40 μg/cm2 (12% 
tail,  p < 0.05). ZnO 
showed statistically 
significant (p < 0.05) 
increased levels of 
oxidative DNA lesions 
compared to those of the 
control in the highest 
dose. 
+ [114] 
ZnO DLS analysis In vitro human 20-30-40 μg/mL for 3h These increases were + [190] 
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hydrodynamic 
diameter: 243.7 
nm (in water), 
273.4 (medium). 
Nominal size 
(BET analysis): 
100 nm. Surface 
area: 15-25 
mg(Provided by 
the supplier) 
neuroblastoma  
SHSY5Y cell line 
and 6h 
 
statistically significant in 
all the conditions tested 
in the comet assay, 
except for the highest 
concentration after the 6 
h exposure. 
 
ZnO 
Nominal size: 20 
and 70 nm. SEM 
analysis: 35 ± 5, 
28 ± 8, 70 ± 19, 
and 72 ± 11 nm. 
DLS 
hydrodynamic 
size ranges from 
200 to 400 nm, 
180 to 300 nm, 
300 to 900 nm, 
and 200to 500 
nm [20 nm (+) 
charge, 20 nm 
(−) charge, 70 
nm (+) 
charge,and 70 
nm (−) charge 
NPs, 
respectively 
In vivo male Crl: 
CD (SD) rats liver 
and stomach 
single cells 
Three dose levels: 500, 
1000, and 2000 mg/kg 
body weight. Test 
substance was 
administered three 
times by gavage at 0, 
24, and 45h 
Tail intensity of liver and 
stomach single cells 
treated with ZnO NPs 
with 20 nm (+) and (−) 
charge had no significant 
increase in comparison 
with solvent control 
group. The results of 70 
nm (+) and (−) charged 
ZnO NPs also revealed no 
significant increase in tail 
intensity. 
- [191] 
ZnO 
DLS particle 
size: 45-150 nm. 
TEM: Spherical, 
triangolare and 
In vitro human 
lymphocyte cells 
0, 125, 500, and 1000 
µg/mL for 3h 
Significant (p < 0.05) 
increase in DNA 
fragmentation at 1000 
µg/mL which is much 
- [192] 
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hexagonal 
structures size 
45-150 nm and 
average 
diameter: 75 ± 5 
nm. 
higher than predicted 
concentrations. These 
NPs are safe up to 500 
µg/mL. 
ZnO 
Nominal size: 
100 nm (NM 
110). TEM 
analysis: 20-
250/50-350 nm. 
DLS analysis 
(MEM): 306 nm 
In vitro human 
hepatoblastoma 
C3A cells 
Three concentration 
levels: 0.62, 1.25 and 
2.5 µg/cm2.Exposure 
duration: 4h 
A small but significant 
increase in percentage 
tail DNA following 
exposure was observed 
+ [156] 
ZnO 
Nominal size: 
10-20 nm. No 
further 
characterization 
reported in the 
paper 
In vivo 
earthworm 
Eisenia fetida 
(Savigny, 1826) 
Four dose levels: 0.1, 
0.5, 1.0, 5.0 g/kg dry 
soil. Exposure duration: 
7 days 
Earthworms exhibited 
DNA damage when 
exposed to ZnO at 1 and 
5 g/kg.  At 5 g/kg the 
degrees of DNA damage 
were significant when 
compared to controls. 
+ [159] 
ZnO 
Nominal size < 
100 nm. TEM 
analysis: rod 
shaped 86 ± 41 
nm X 
42 ± 21 nm; 
mean diameter 
was 353 nm 
In vitro primary 
human nasal 
mucosa cells 
Five concentration 
levels: 0.01, 0.1, 5, 10 
and 50 µg/ml. Exposure 
duration: 24h 
A ZnO-NP concentration-
dependent increase in 
the Olive Tail Moment 
(OTM) as an indicator for 
genotoxic effects could 
be seen. The enhanced 
DNA migration was 
significant at 10 µg/ml 
and 50 µg/ml. 
+ [193] 
ZnO 
Nominal size: 
50–80 nm size 
and average 
In vitro Allium 
cepa root 
Three concentration 
levels: 10,100 and 1000 
µg/ml. Exposure 
The results obtained in 
the comet assay show 
that both tested ZnO NPs 
+ [165] 
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particle size ≤ 
35 nm. DLS 
analysis: 50 ± 
0.3 
nm for ZnO 50 
nm NPs and 35 
± 1.1 nm for 
ZnO NPs (≤ 35 
nm) 
meristem cells duration: 1h are genotoxic in the root 
meristem cells of A. cepa 
in terms of both the 
percentage of DNA in tail 
and tail moment. 
ZnO 
Nominal size: 
50–80 nm size 
and average 
particle size ≤35 
nm. DLS 
analysis: 50.75 ± 
0.0 nm for ZnO 
50–80 nm) 
NPsand 36.42 ± 
0.1 nm for ZnO 
(≤35 nm) NPs 
In vitro human 
embryonic kidney 
(HEK293) and 
mouse embryonic 
fibroblast 
(NIH/3T3) cells 
Three concentration 
levels: 10,100 and 1000 
µg/ml. Exposure 
duration: 1h 
The results show that 
both tested ZnO NPs are 
genotoxic in the two cell 
lines used. The 
significance of the 
genotoxicity results were 
independently of using 
the percent-age of DNA in 
tail or the tail moment. 
The induced genotoxicity 
followed a direct dose–
response effect with 
positive induction at 100 
and 1000 µg/mL 
concentrations 
+ [194] 
ZnO 
TEM analysis: 17 
nm. DLS 
analysis: 
average 
hydrodynamic 
size 263.0 nm 
(in medium) 
In vitro human 
skin melanoma 
(A375) cells 
Three concentration 
levels: 5, 10 and 20 
µg/ml. Cells were 
treated for 24 and 48h 
Cells exposed to different 
concentrations of ZnO 
NPs showed significantly 
more DNA damage than 
did the control cells. 
+ [195] 
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ZnO 
Nominal 
average 
particle size: 50 
nm. TEM 
analysis: 22 nm. 
DLS analysis: 
average 
hydrodynamic 
size 264.8 nm 
(in water) 
In vivo freshwater 
snail Lymnaea 
luteola digestive 
gland cells 
Three dose levels: 10, 
21 and 32 µg/ml. 
Isolation of digestive 
gland cells was done at 
intervals of 24 and 96h 
The cells exposed to 
different concentrations 
of ZnO NPs exhibited 
significantly higher DNA 
damage in cells than 
those of the control 
groups. 
+ [196] 
ZnO 
Nominal size: 
<100 nm. DLS 
analysis: 
612 ± 10.9 nm 
(water) 
5294 ± 3184 nm 
(medium) 
 
In vitro 
S. cerevisiae cells 
One concentration 
level: 31.25 mg/l. No 
information about time 
exposure 
A significant amount of 
DNA damage was 
detected in NP-exposed 
cells when compared 
with controls. 
+ [121] 
ZnO 
SEM analysis: 
40-70 nm. 
 
In vitro 
lymphocytes and 
sperm cells 
Approximately 4–93 
μg/mL in PBS for 30 min 
in the dark, 
preirradiated and 
simultaneous irradiation 
with UV 
The ZnO particles are 
capable of inducing 
genotoxic effects on 
human sperm and 
lymphocytes and that the 
effect of ZnO is enhanced 
by UV both in case of 
lymphocytes and sperm, 
but effects are only 
statistically significantly 
different from responses 
in the dark at the highest 
+ [155] 
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Table 2. Current review of genotoxicity studies (Micronucleus test) on metal oxide NPs (+ positive; - negative; +/- equivocal; bw = 
body weight). As explained in section 3, each row in this table summarizes all genotoxicity data found for this test for all 
nanomaterials with a given core chemical composition reported in a given publication. 
Nanomater
ial core 
chemical 
compositio
n  
Characteristics (Size) 
Cell type and 
assay 
Exposure 
Results 
 
Summar
y 
Ref. 
Al2O3 
Two aluminium oxide 
NMs were studied. 
Nominal diameter: 30 
nm and 40 nm. TEM 
analysis: 39.85±31.33 nm 
and 47.33±36.13 nm 
In vivo inbred 
female albino 
Wistar rats 
bone 
marrow cells  
Three dose levels (oral 
administration): 500, 
1000 and 2000 mg/kg 
body weight. The 
study was performed 
at 30 and 48 h of 
sampling times 
Significantly increased frequency of 
MN was observed with 1000 and 
2000 mg/kg body weight dose 
levels of Aluminum oxide 30 nm 
and Aluminum oxide 40 nm over 
control at 30 h. Likewise, at 48 h 
sampling time a significant increase 
in frequency of MN was evident at 
1000 and 2000 mg/kg body weight 
dose levels of Aluminum oxide 30 
nm and Aluminum oxide 40 nm 
+ 
[197] 
 
does after pre-irradiation 
and simultaneous 
irradiation. 
ZrO2 
Nominal size: 6 
nm. TEM 
analysis: 
average 
hydrodynamic 
diameter  6 ± 
0.8nm. 
In vitro human 
embryonic kidney 
(HEK293) cells 
and  human 
peripheral blood 
lymphocytes 
Concentrations of 1, 10, 
or 100 μg/mL 
Results demonstrated 
that at all concentration 
NP did not induce any 
marked genotoxicity. 
- [103] 
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compared to control. 
Al2O3 
Two aluminium oxide 
NMs were studied. 
Nominal diameters: 30 
nm and 40 nm. TEM 
analysis: 39.85 ± 31.33 
nm and 47.33 ± 36.13nm. 
DLS analysis:  average 
diameters 212.0 and 
226.1 nm in water. 
In vivo female 
Wistar rat 
peripherial 
blood cells 
Three dose levels (via 
gavage): 500, 1000 
and 2000 mg/kg body 
weight. Whole blood 
was collected at 48 
and 72 h 
 
Data indicated statistically 
significant effects on micronuclei 
frequency after treatment with 
both NMs compared to the control 
group at 1000 and 2000 mg/kg 
dose levels after 48 and 72 h. 
+ [81] 
CeO2 
Nominal size < 25 nm. 
TEM analysis: 25 ± 1.512 
nm. DLS analysis:   
hydrodynamic diameter 
269.7 ± 27.398 nm 
In vitro human 
neuroblastoma 
(IMR32) cells 
Five concentration 
levels: 10, 20, 50, 100, 
and 200 mg/ml. 
Exposure duration: 24 
h 
At concentration levels of 100 and 
200 mg/ml the frequency of 
micronucleus in binucleated cells 
was increased significantly.  
+ [106] 
CeO2 
Nominal size: 7 nm. DLS 
analysis: hydrodynamic 
diameter 15 nm 
 
In vitro human 
dermal 
fibroblasts 
Four concentration 
levels: 0.06, 0.6, 6 and 
60 mg/l. Exposure 
duration: 48 h 
Binucleated micronucleated 
fibroblast frequencies were 
significantly increased in a dose-
dependence manner from the 
lowest tested concentrations (0.06 
mg/l) 
+ [107] 
CuO 
Four different CuO 
nanoparticles were 
studied, with the 
following size 
measurements and 
shapes determined by 
In vitro human 
murine 
macrophages 
RAW 264.7 cells 
and peripheral 
blood 
Three concentration 
levels: 0.1, 1 and 10 
μg/ml. Exposure 
duration: 48 h 
In all tested NMs, macrophages 
showed a higher number of 
micronucleated cells than 
lymphocytes, except for the NM 
(1). Spheres and spindles showed a 
dose-dependent increase in the 
+ [115] 
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TEM: (1) 10-100 nm 
(unspecified shape); (2) 
7±1 nm (spheres); (3) 
7±1×40±10 nm (rods); (4) 
1200±250×270±50×30±1
0 nm (spindles) 
lymphocytes 
(PBL). 
micronuclei frequency in 
macrophages.   
CuO 
Two different CuO NMs 
were studied. 
Nominal average size 
between 30 and 40 nm. 
SEM analysis: diameter 
between 70 and 100 nm. 
TEM analysis: protein–
NPs complex had a total 
average size of 356 ± 70 
nm 
In vitro mouse 
neuroblastoma 
(Neuro-2A) cells  
Four concentration 
levels: 12.5, 25, 50 and 
100. Exposure 
duration: 24 h  
Treated cells showed a significant 
increase in the frequency of 
micronuclei at the lowest 
concentration level 
+ [198] 
CuO 
 
Nominal size between 
27.2 and 95.3 nm  
 
In vivo female 
ICR mice 
peripheral 
blood cells 
Two dose levels 
(intraperitoneal 
injection): 1 
mg/mouse and 3 
mg/mouse. Exposure 
time: 24, 48 and 72 h 
A significant 
differences was observed  between 
control and 3 mg doses treated 
cells 
+ [86] 
Fe2O3 
Nominal size 
 < 50 nm. TEM analysis: 
mean size 29.75 ± 1.87 
nm. DLS analysis: 
hydrodynamic diameter 
363 nm (water) 
In vivo albino 
Wistar female 
rat peripheral 
blood and bone 
marrow cells  
Three dose levels (oral 
administration): 500, 
1000 and 2000 mg/kg 
body weight. 
Peripheral blood cells 
exposure duration: 48 
and 72 h. Bone 
marrow cells exposure 
duration: 24 and 48 h  
The frequencies of micronuclei 
were statistically insignificant at all 
doses in both cell lines and at every 
exposure duration 
- [126] 
Fe2O3 
 
Nominal size between 60 
and 100 nm 
In vivo female 
ICR mice 
peripheral 
Two dose levels: 1 
mg/mouse and 3 
mg/mouse. Exposure 
A significant increase in 
micronucleated 
reticulocytes cells was observed 
+ [86] 
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blood cells time: 72 h 
Fe3O4 
Nominal size between 20 
nm and 60 nm. Photon 
correlation spectroscopy 
(PCS) analysis: mean 
diameter 311 nm 
In vitro human 
lung 
adenocarcinom
a 
type-II alveolar 
epithelial cells 
A549 
Four concentration 
levels: 1, 10, 50 and 
100 μg/cm2. Exposure 
duration: 24 h 
A significantly enhanced MN 
induction was already observed at 
10 μg/cm2,  reaching a maximum at 
100 μg/cm2 
+ [131] 
Fe3O4 
 
TEM analysis: primary 
diameter of 26.1 ± 5.2 
nm 
In vivo kunming 
mice bone 
marrow cells 
Four dose levels: 5, 
2.5, 1.25, and 0.625 
g/kg. The 30 h 
injection method was 
used, ie, a 24 h 
interval between two 
injections with a 6-
hour wait after the 
second injection 
No significant difference was found 
between the test animals and the 
negative controls 
- [199] 
Fe3O4 
 
Nominal size: 80 nm 
In vivo female 
ICR mice 
peripheral 
blood cells 
Two dose levels: 1 
mg/mouse and 3 
mg/mouse. Exposure 
time: 72 h 
Significant increases in 
micronucleated 
reticulocytes cells was observed 
+ [86] 
MnO2 
MnO2 nanopowder 
nominal size of <30 nm. 
TEM analysis: mean size 
distribution 45 
± 17 nm. DLS size in the 
Milli Q water suspension 
was 334.4 nm 
In vivo bone 
marrow cells 
extracted from 
the femurs of 
female albino 
Wistar rats 
Three dose levels: 100, 
500 and 1000 mg/kg 
body weight. 
The study was 
performed at 24 and 
48 h after treatment 
The data revealed statistically 
significant enhancement in the MN 
frequency in the groups treated 
with 1000 mg/kg body weight of 
MnO2-45 nm at 24 and 48 h of 
sampling times 
+ [128] 
SiO2 
(amorphou
s) 
Nominal size: 15 nm and 
55 nm. DLS analysis: z-
average particle 
diameter (pH 7.5) 31.6 
nm and 105.1 nm 
In vitro human 
peripheral 
blood 
lymphocytes 
(HPBLs); In vivo 
Wistar rat 
(In vitro) Four 
concentration levels: 
31.6, 100, 316, 1000 
μg/mL. Exposure 
duration 24h. (In vivo) 
Single concentration 
For both the 15 nm and 55 nm 
silica NPs, no increase in the % MN 
was observed with any of these 
particles at any dose tested in this 
in vitro system in HPBLs. (In vivo) 
Injection of silica NPs resulted in a 
+/- [82] 
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peripheral 
blood cells 
for 15 nm SiO2: 50 
mg/kg; two 
concentration levels 
for 55 nm SiO2: 25 
mg/kg and 125 mg/kg. 
Rats injected i.v. at 
48h, 24h, and 4h prior 
to tissue collection 
dose-dependent increase in DNA 
damage in liver and lung tissue and 
in white blood cells 
SiO2 
(amorphou
s) 
DLS analysis: 
hydrodynamic diameter 
12 nm in DMEM and 75 
nm in DMEM + 10%FBS 
In vitro A549 
human lung 
carcinoma cells 
Three concentration 
levels: 1.5, 2.5, 5 
μg/mL. Cells were 
treated for 40h 
 
No induction of MN was observed 
compared to the untreated control 
both in 10% serum and in 0% 
serum 
- [200] 
SiO2 
(amorphou
s) 
DLS hydrodynamic 
diameter: ranging from 
12 nm to 174 nm without 
foetal calf serum (FCS) 
and from 52 nm to 258 
nm in FCS 
In vitro A549 
human lung 
carcinoma cells 
Concentrations range 
between 0 μg/mL and 
1056 μg/mL. Cells 
were treated 
for 40h with different 
doses of the SNPs 
either in presence or 
absence of 10% FCS 
A statistically significant increase in 
MN frequencies was observed 
after treatment with L-40 in the 
absence of serum as well as with L-
40 and S-174 in the presence of 
serum and after treatment with L-
40, S-59 and S-139 in the absence 
of serum. No dose dependency was 
observed 
+ [201] 
SiO2 
(amorphou
s) 
Nominal size: ranging 
from 5 nm to 80 nm. DLS 
analysis: mean particle 
diameter between 17.42 
± 0.16 and 185.1 ± 7.51 
in ultrapure water; 
between 16.08 ± 0.81 
and 332.6 ± 11.42 in 
serum-free cell culture 
medium 
In vitro Balb/3T3 
mouse 
fibroblasts 
Cells were treated at 
the fixed 
concentration of 100 
μg/mL for 24h 
SiO2 NPs did not trigger the 
formation of micronuclei, 
suggesting that neither the size 
diameter nor the particles’ 
synthesis procedure induces 
genotoxicity 
- [202] 
SiO2 
(quartz) 
Nominal size: diameter 
<5 μm. 
In vitro WIL2-NS 
(ATCC, CRL 
Two concentration 
levels: 60, and 120 
The results show that the 
frequency of 
+ [138] 
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High-performance 
particle sizer (HPPS) 
analysis after filtration: 
Z-Average size 12.2 nm 
8155) human 
lymphoblastoid 
B-cell 
μg/mL. Cyt-B was 
added and the 
cultures were 
incubated for 26h 
MNed BNCs increased significantly 
with the increase of particle dose, 
from 5 MN per 1000 BNed cells at 
untreated control to 12 at 120 
μg/mL of particles 
TiO2 
TEM analysis: 12.1 ± 3.2 
nm. Agglomerates 
in the treatment solution 
was found to be around 
130 nm and around 170 
nm in cell culture 
medium 
In vivo male 
B6C3F1 mice 
blood cells 
Three dose level: 0.5, 
5.0 and 50 mg/kg for 
three consecutive 
days 
No difference in %MN-RET 
frequencies between TiO2-NP 
treated and control animals was 
observed 
- [203] 
TiO2 
X-ray diffraction (XRD) 
analysis: diameter 
ranging from 7 nm to 10 
nm. DLS analysis: 
hydrodynamic diameter 
ranging from 139 nm to 
211 nm in DMEM and 
from 109 nm to 233 nm 
in DMEM + 10%FBS 
In vitro A549 
human lung 
carcinoma cells 
Four concentration 
levels: 50, 75, 125, 250 
μg/mL. Cells were 
treated for 40h 
 
Results are not available as the MN 
were obscured by NM 
agglomerates over the cells and 
thus could not be scored 
+/- [200] 
TiO2 
Nominal size: 25 nm. DLS 
analysis: mean particle 
size 300 nm 
In vitro human 
lymphocytes 
and hamster 
lung fibroblasts 
V79 cells 
Four concentration 
levels: 20, 60, 100 and 
250 μg/mL. Cells were 
exposed without 
metabolic activation 
system for 24h 
Weak mutagenic effect on human 
lymphocytes at 60–250 μg/mL 
+ [146] 
TiO2 
Nominal size: 40 ± 5 nm. 
SEM analysis: average 
size distribution 42.30 ± 
4.60 nm 
In vivo ICR mice 
bone marrow 
cells 
Four dose levels: 140, 
300, 645, and 1387 
mg/kg body weight. 
Blood samples were 
collected 14 days after 
treatment 
Micronucleus test result 14 days 
after a single intravenous injection 
of different doses of TiO2 NPs 
shows no significant 
increase in micronucleus cell 
number 
- [204] 
TiO2 Nominal size < 25 nm. In vivo P. The fish were exposed Micronuclei were not detected, but - [148] 
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DLS  hydrodynamic size 
(Z-average): 1611 ± 21 
nm after 24h 
mesopotamicus 
(pacu caranha) 
erythrocytes 
cells 
(with visible light or 
ultraviolet and visible 
light) to the following 
concentrations of 
nano-TiO2 during a 96 
h period: 0 (control), 
1, 10, and 100 mg/l. 
the extent of morphological 
alterations 
in the erythrocyte nuclei revealed 
an influence of the type of 
illumination, since the alterations 
were more prevalent in groups 
exposed to UV light 
TiO2 
Nominal size: 21 nm. DLS 
hydrodynamic diameter: 
129.50 ± 2.6 nm 
In vivo Adult 
male Wistar rats 
bone marrow 
cells 
Single dose of 5 mg/kg 
body weight. Animals 
were sacrificed at 24h, 
1 week and 4 weeks 
after the injections 
A significantly elevated frequency 
of MN was observed for TiO2NPs 
after 24h. The frequencies of 
micronuclei were statistically 
insignificant after 1 and 4 weeks. 
+ [147] 
TiO2 
Nominal average size: 75 
± 15 nm. ZetaSizer Nano 
ZS90 hydrodynamic 
diameter: 473.6 nm and 
486.8 nm size when 
suspended in H2O and 
FBS-free DMEM 
In vivo Sprague-
Dawley male rat 
bone marrow 
cells 
Three dose levels: 10, 
50 and 200 mg/kg 
body weight every day 
for 30 days 
These results showed that TiO2NPs 
could induce DNA double strand 
breaks in bone marrow cells after 
oral administration, but no 
significant chromosomes or mitotic 
apparatus damage and toxicity 
were found in bone marrow cells. 
+ [149] 
TiO2 
UF-TiO2 particle size ≤ 20 
nm. No further 
investigations are 
reported in the paper 
In vitro Syrian 
hamster 
embryo (SHE) 
cells. 
Cells were 
treated with different 
concentrations: 0.5, 
1.0, 5, and 10 μg/cm2, 
for different periods: 
12, 24, 48, 66, and 72 
h 
UF-TiO2 induced MN, which 
significantly  increased at 
concentrations between 0.5 and 
5.0 μg/cm2 
+ [205] 
TiO2 
TiO2 anatase at 10 nm 
(Hombikat UV100) and 
20 nm (Millenium PC500) 
in diameter. No further 
investigations are 
reported in the paper 
In vitro human 
bronchial 
epithelial cells, 
BEAS-2B (ATCC 
CRL-9609) 
Cells were treated 
with 10 g/mL of TiO2 
for 24 h 
The results indicated that 
treatment with anatase-sized (10 
and 200 nm) TiO2 increased 
micronuclei 
+ [169] 
TiO2 
No characterization of 
the NM is reported in the 
In vitro Chinese 
hamster ovary-
Cells were treated 
with various 
Results show that TiO2 significantly 
induced MN in CHO-K1 cells using 
+ 
 
[206] 
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paper K1 (CHO-K1) 
cells 
concentrations of TiO2 
(0 to 20 μM) for 18h 
cytokinesis block 
technique. Furthermore, the 
frequency of MN was slightly 
enhanced by TiO2 in the 
conventional MN assay system, i.e., 
without cytokinesis block 
TiO2 
Ultrafine TiO2 (UF1 - 
uncoated anatase) 
average crystal sizes: 20 
nm.  No further 
investigations are 
reported in the paper 
In vitro rat liver 
epithelial cell 
(RLE) 
Three concentrations: 
5, 10 and 20 μg/cm2. 
All the cultures were 
treated with 
cytochalasin B and 
incubated for 20 h. A 
duplicate series of 
experiments was 
carried out by 
irradiating the TiO2 
exposed cells with 
near-UV light 
No observed increase of the 
number of micronucleated cells. 
Exposure of the cells to UV light 
gave a slight but not statistically 
significant effect, Interestingly, TiO2 
appeared to have a slight 
decreasing effect on the frequency 
of micronuclei at the lowest 
treatment concentrations both in 
the presence and in the absence of 
UV irradiation. 
- [207] 
TiO2 
Particle size distribution 
measured by high-
performance particle 
sizer (HPPS): by volume 
6.57 nm (100%); by 
intensity: 8.2 nm (80.4%) 
and 196.52 nm (19.4%) 
In vitro WIL2-NS 
human 
lymphoblastoid 
cells 
Cells were treated 
with 26, 65 and 130 
μg/mL of UF-TiO2. Cyt-
B was added and the 
cultures were 
incubated for 26h 
Exposure to UF-TiO2 resulted in 
significant increases in MNBNCs 
compared to untreated control. 
+ [173] 
TiO2 
Nominal size: 19.7–101.0 
nm. No further 
investigations are 
reported in the paper 
In vivo female 
ICR mice 
peripheral 
blood cells 
Two dose levels: 1 
mg/mouse and 3 
mg/mouse. Exposure 
time: 72h 
Significant increases in 
micronucleated 
reticulocytes (MNRETs) observed 
+ [86] 
TiO2 
TEM analysis: cross 
sectional diameter 24.4 ± 
0.5 nm 
In vitro RTG-2 
gonadal tissue 
fish cell line 
from rainbow 
trout 
Two concentration 
levels: 5 and 50 
μg/mL. 
48h time exposure 
before adding the 
No significant difference in 
micronuclei induction over the 
control. Decreases in frequencies 
of MN were observed with 
the ENP treatments, which in 
- [172] 
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 cyto-B for 48 h addition, had little effect on cell 
division or cytotoxicity 
V2O3 
Nominal size of spherical 
diameter: approximately 
70 nm. TEM average 
diameter: 25 nm. TEM 
length: 100 – 1.000 nm. 
(Needle-like structure) 
 
In vitro human 
epithelial lung 
cell line (A549) 
Two exposure levels: 1 
and 2 μg/cm2. 24 
hours time of 
exposure via 
inhalation 
No induction of micronuclei was 
observed in the micronucleus test 
but morphological changes in cell 
nuclei. 
- [52] 
V2O5 
Nominal size of spherical 
diameter: 170 –180 nm. 
They are up to several 
hundred nanometer in 
length and usually have a 
diameter of less than 50 
nm. (Rod-shaped) 
 
In vitro human 
epithelial lung 
cell line (A549) 
Two exposure levels: 1 
and 2 μg/cm2. 24 
hours time of 
exposure via 
inhalation 
No induction of micronuclei was 
observed in the micronucleus test 
but morphological changes in cell 
nuclei. 
- [52] 
WO3 
No characterization of 
the NM is reported in the 
paper 
In vivo bone 
marrow cells of 
male Sprague-
Dawley rats 
Three dose levels: 25, 
50 and 100 mg/kg 
body weight. Animals 
received daily 
intraperitoneal 
injections of WO3 for 
30 days. 
No statistically significant 
difference was found between 25 
mg WO3 applied and control group. 
On the contrary, the higher doses 
of WO3 (50 and 100 mg) caused 
increases of MN rates 
+ [83] 
ZnO 
Nominal size: 20 and 70 
nm. SEM analysis: 35 ± 5, 
28 ± 8, 70 ± 19, and 72 ± 
11 nm. DLS 
hydrodynamic size 
ranges from 200 to 400 
nm, 180 to 300 nm, 300 
to 900 nm, and 200to 
500 nm [20 nm (+) 
charge, 20 nm (−) charge, 
In vivo Out-bred 
mice of strain 
ICR, 6–7 bone 
marrow cells 
Three dose levels: 500, 
1000, and 2000 mg/kg 
body weight. The test 
substance was given 
twice with a 24h 
interval 
The frequencies of MNPCE 
(micronucleated polychromatic 
erythrocyte) were not represented 
statistical significance and dose-
dependent response at any dose 
on four kinds of ZnO NPs 
- 
 
[191] 
65 
 
70 nm (+) charge,and 70 
nm (−) charge NPs, 
respectively 
ZnO 
X-ray diffraction (XRD) 
analysis: diameter 
ranging from 71 to >100. 
DLS analysis: 
hydrodynamic diameter 
250 (±100) in DMEM and 
258 (±93) in DMEM + 
10%FBS 
In vitro A549 
human lung 
carcinoma cells 
Three concentration 
levels: 10, 25, 50 
μg/mL. Cells were 
treated for 40h 
 
No significant increase in MN was 
shown for ZnO NM, except at the 
highest dose tested (50 μg/mL) in 
the presence of 10% serum, where 
high toxicity was observed 
- [200] 
ZnO 
Nominal size < 100 nm. 
DLS analysis: effective 
diameter 120 ± 2.6 nm 
In vitro A. cepa 
root cells 
Four concentration 
levels: 25, 50, 75 and 
100 μg/mL. Exposure 
duration: 4h 
Dose dependent increase of MN 
was observed. 
+ [208] 
ZnO 
TEM analysis: particle 
size 29 ± 10 nm 
In vitro WIL2-NS 
human 
lymphoblastoid 
cells 
Cells were cultured 
with 10 mg/l NPs for 
24h 
The assessment of DNA damage 
indicated significant increases in 
the frequency of MNi in cells 
exposed to OA-coated and PMAA-
coated NPs, respectively, 
whereas there was no significant 
elevation of MNi found in cells 
exposed to uncoated or medium-
coated NPs 
+/- [209] 
 
Table 3. Current review of genotoxicity studies (Ames test) on metal oxide NMs. As discussed in section 3.3, in the Ames test one or more 
strains of Salmonella (S. typhimurium) and/or E. coli are used e.g. the S. typhimurium strains (TA) TA97a, TA98, TA100, TA102, TA1535 and 
TA1537 or the E. coli strain WP2u-vrA⁻ referred to in Table 3. It can also be used with or without metabolic activation i.e. typically with or 
without “S9- mix”. Typically, a single “positive” result in any one of these combinations results in the outcome of the Ames test being “positive” 
[97]. As explained in section 3, each row in this table summarizes all genotoxicity data found for this test for all nanomaterials with a given core 
chemical composition reported in a given publication. 
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Nano
mater
ial 
core 
chemi
cal 
comp
ositio
n 
size (nm) 
 
Ames 
outco
me 
TA97a 
TA97a 
+S9 
TA98 
TA98 
+S9 
TA100 
TA100 
+S9 
TA102 
TA102 
+S9 
TA153
5 
TA153
5 +S9 
TA153
7 
TA153
7 +S9 
E. coli 
WP2u
-vrA⁻ 
E. coli 
WP2u
-vrA⁻ 
+S9 
publica
tions 
 
Al2O3 <50 - - -   - -       - - [210] 
Al2O3 30-40 - - - - - - - - - - -     
[81, 
197] 
Co3O4 <50 - - -   - -       - - [210] 
CuO <50 + -  +   + +       + 
colony 
inhibit
ion 
[210] 
Fe3O4 
8.0 ±2 
(10-
30ppm) 
-   - - - - - -       [132] 
Fe3O4 
8.0 ±2 
(70ppm) 
 +   - - - + - -       [132] 
TiO2 50 +   + + - -   - - + + + + [211] 
TiO2 <100  + -    -         +  + [210] 
TiO2 10 -   -  -  -  -  -    [174] 
TiO2 <100 +   + + - +         [213] 
ZnO 5.4 -   - - - -     - - - - [214] 
ZnO 30  +   -  + - -   - - -  + -  + [211] 
ZnO <100  + -    -         +  + [210] 
ZnO 
 
100 -   -  -      -  -  [215] 
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ZnO 
20 and 70 
 
-   - - - -   - - - - - - [191] 
WO3 <100  +   +  -    -    -  [216] 
In2O3 <100  +   +  -    -    -  [216] 
Dy2O3 <100 +   +  +    +    +  [216] 
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4. Survey of available genotoxicity data for metal oxide NMs in the literature 
In order to estimate an overall situation with genotoxicity tests for NPs, we have performed a literature 
search in the Scopus online database, searching articles published from January 1997 until July 2014 
using the keywords: “genotoxicity” and “nanomaterial” or “nanoparticle”.  The results of literature 
search were last updated in July 2014. The search identified more than 600 publications which 
contained the keywords mentioned above; the distribution of years of publication is shown in Figure 2. 
From these publications, 165 reporting experimental data relating only to metal oxide/silica NMs’ 
genotoxicity were selected. The data presented in these publications are summarized in Tables 1-3.  
 
Furthermore, the selected publications were analyzed, identifying the particular genotoxicity test used, 
with Figure 3 showing the trend in the number of publications per year for each test type. Interestingly, 
the comet assay appears to be the most popular genotoxicity test for NMs at the current time. 
Furthermore, the number of publications reporting NM studies using the comet assay increases year on 
year, while the number of publications reporting use of the, currently second most popular, 
micronucleus test appears to be declining. Among the other two tests considered, the Ames and 
chromosome aberration tests, the use of the chromosome aberration test would appear to be declining 
whilst the Ames test is becoming increasingly popular for NMs, in spite of warnings regarding its 
suitability for NMs [37, 101].   
From the 165 articles with genotoxicity data (Tables 1-3), 137 genotoxicity studies describe the use of 
the comet assay, 38 the micronucleus assay, 20 the Ames test and 6 the chromosome aberrations test 
(some papers include two or three tests), (Figure 4).  
Based on Table 4 we can see that TiO2, SiO2 and ZnO NMs are the most assessed NMs, out of the group 
of metal oxides/silica considered in this review, in genotoxicity studies (Table 4). The other types of NMs 
evaluated in these studies, out of the group of metal oxides/silica considered in this review, are, in 
descending order of number of publications presenting genotoxicity studies of NMs, as follows: Fe3O4, 
Fe2O3, CuO, Al2O3, CeO2, Co3O4, NiO, MnO2, WO3, V2O5, Dy2O3, In2O3, ZrO2, MgO, V2O3, Bi2O3 NMs. 
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Figure 2. Literature results in terms of number of papers per year on genotoxicity of NMs performed in 
the Scopus online database from year 1997 using “nanoparticle”or “nanomaterial” and “genotoxicity” as 
key words. 
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Figure 3. Number of publications per each genotoxicity test in a range from 1997 to 2014 (July). 
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Figure 4. Ranking of genotoxicity tests by the number of publications reporting their use for evaluating - 
the tests that are more frequently used for evaluation of MeOx and silica NMs genotoxicity. N.B. This 
figure reflects the information on total number of publications, given in Table 4. 
 
Table 4. Ranking of different kinds of metal oxide/silica NMs by: a) Number of publications reporting 
genotoxicity evaluations by different tests, b) Datum point for each assay performed for each type of 
nano metal oxide/silica. 
Nano 
metal 
oxides  
Number of 
publications
a  
Cometb   Micronucle
usb 
Amesb  Chromoso
me 
aberrationb  
Total 165 137 39 20 6 
TiO2 63 53 14 5 2 
ZnO 25 21 4 5 1 
SiO2 18 15 5    
CuO 14 11 3 2   
Fe3O4 10 9 3 2   
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Fe2O3 9 8 2     
CeO2 7 7 2     
Al2O3 5 3 2 2 1 
Co3O4 3 2   1   
MnO2 2 2 1   1 
V2O5 1 1 1     
Bi2O3 1 1    
Dy2O3 1     1   
In2O3 1     1   
MgO 1 1       
NiO 1 1       
V2O3 1 1 1     
WO3 1   1 1 1 
ZrO2 1 1       
 
 
5. Mechanisms of metal oxide/silica NM-induced genotoxicity 
The knowledge of the various possible mechanisms of NMs’ toxicity and genotoxicity, in 
particular, is critically important in order to assess the level of hazard posed by NMs towards 
the environment and living organisms. Inorganic materials can interfere with the delicate 
balance of cellular homeostasis and hereby alter intracellular signaling pathways, resulting in 
cascade of possible effects. As for all NMs, the detailed mechanisms of genotoxicity for metal 
oxide/silica NMs are still not well understood, and as was discussed in [26, 60] it is often not 
clear if an effect on DNA is “nano-specific”. By “nano-specific effect”, we mean that the 
mechanism of toxic action is specific to particles with initial dimensions within the size range 1-
100 nm as opposed to also being associated with particles of different size but with the same 
chemical composition. In general, particle induced genotoxicity may be classified as either 
“primary genotoxicity” or “secondary genotoxicity”, where “secondary genotoxicity” refers to 
the induction of genotoxicity via reactive oxygen species (ROS) generated during particle-
elicited inflammation and “primary genotoxicity” refers to genotoxicity induced in the absence 
of inflammation [217] . There are studies that suggest primary genotoxicity could be the result 
of direct interaction of NMs with DNA, as well as studies that confirm indirect damage from 
NM-induced reactive oxygen species (ROS) formation, or by toxic ions released from soluble or 
even from low soluble NMs [57, 107, 116, 139, 172, 189, 218-220]. At the same time, secondary 
genotoxicity may result from DNA attack by ROS generated via activated phagocytes 
(neutrophils, macrophages) during NM-elicited inflammation [60, 221]. A more detailed 
discussion regarding possible metal oxide/silica NM genotoxicity mechanisms of action is given 
below. 
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5.1. Direct primary genotoxicity 
As soon as particles enter the nucleus, they have the potential to interact directly with DNA 
molecules. During these interactions, the metal oxide/silica NMs might bind and influence DNA 
replication or disturb other DNA processes, for example, transcription to RNA [222]. 
Several studies support the hypothesis of direct primary genotoxicity of NMs indicating binding 
with DNA [223-236], although many of them are computational studies [228-230, 232-235]. 
Palchoudhury et al [224], using gel electrophoresis, studied platinum-attached iron oxide NMs’ 
interaction with DNA and showed that DNA has strong interaction with iron oxide NMs’ 
attached to platinum. Tang et al [225] investigated the interaction of cadmium quantum dots 
with DNA and, using circular dichroism spectroscopy, indicated that the Cd-MAA complex might 
interact with DNA fragments. Rice et at [226] studied the interactions of TiO2-NMs with DNA 
and, using adsorption studies, showed that terminal phosphate groups influence binding of 
DNA to TiO2. In another study, Wahab et al [227] investigated ZnO-NMs by various 
spectroscopy methods and observed the interaction of zinc oxide NMs with DNA by UV-vis and 
atomic force microscopy (AFM) spectroscopy. The dissociation of double-stranded DNA 
(dsDNA) by small metal NMs (5nm Au) was observed through a series of DNA melting transition 
measurements by Yang et al [236], which confirms the strong non-specific interaction between 
DNA and metal NMs. In addition to the experimental studies discussed, a number of 
computational studies support the scarce experimental evidence that metal oxide NMs can 
interact with DNA bases and DNA fragments [228-230, 232-235]. For example, Shewale et al 
[234], applying first-principles calculations, identified possible interactions of ZnO clusters with 
DNA nucleobases. Fahrenkopf et al [228], using density functional theory (DFT) calculations, 
showed the interaction between hafnium dioxide NMs and DNA, suggesting that the 
interactions were predominantly mediated by the terminal phosphate in an oriented manner. 
Jin et al [229] used DFT calculations to indicate strong interactions between Al12X (X=Al, C, N 
and P) NMs and DNA base pairs, suggesting that Al-based NMs might affect structural stability 
of DNA and cause structural damage. In another computational study, Paillusson et al [232] 
investigated interactions between model NMs and DNA. They investigated the influence on the 
effective interaction of the following conditions: the shape of the NP, the magnitude of the 
nanoparticle charge and its distribution, the value of the pH of the solution, the magnitude of 
Van der Waals interactions, depending on the nature of the constitutive material of the NM 
(metal vs. dielectric), and showed that, for positively charged concave NPs, the effective 
interaction is repulsive at short distances i.e. the interaction energy shows a minimum at a 
finite distance from the DNA.  
5.2. Indirect primary genotoxicity 
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The indirect mechanisms of nanoparticle primary genotoxicity were recently reviewed 
systematically [60]. Here we discuss only those mechanisms applicable to metal oxide NPs. In 
fact, to cause damage, metal oxide NPs do not need to be in direct contact with DNA. Some 
possible indirect genotoxicity mechanisms for metal oxide NPs include: interaction with nuclear 
proteins (involved in replication, transcription, and repair), disturbance of cell cycle checkpoint 
functions, ROS arising from the NP surface, release of toxic metal ions from the NP surface, ROS 
produced by cell components, and inhibition of antioxidant defense [54, 110, 237]. Several 
experimental studies have shown that indirect DNA damage might be caused by oxidative 
stress initiated by ROS species generated by metal oxide NPs [92, 109, 114, 116, 238-246]. 
 
5.3. Secondary genotoxicity 
Metal oxide/silica NMs interactions may cause secondary genotoxicity via the following 
pathway: NMs trigger ROS production by inflammatory cells (neutrophils and macrophages), 
i.e. in this case ROS are not generated by the NM itself or by ions leaching from the NM surface, 
but by inflammatory cells via an inflammation signaling pathway. Several publications 
confirmed the genotoxicity of metal oxide NMs being associated with inflammation processes 
[59, 87, 89, 186, 247-252]. 
 
6. Brief overview of experimental data identified and comparative analysis of 
genotoxicity for metal oxide/silica NMs 
This section provides a brief overview of the experimental data identified generalizing the data 
represented in Tables 1-3 and discussing the main findings.  
 
6.1. Toxicity of NMs compared to their micrometer-sized and bulk counterparts 
Karlsson et al [31] compared the ability of nano-sized (<100 nm) and micrometer-sized (<5 μm) 
particles of some metal oxides (Fe2O3, Fe3O4, TiO2 and CuO) to cause cell death, mitochondrial 
damage, DNA damage and oxidative DNA lesions after exposure to the human cell line A549. 
This publication reported that NPs of CuO were much more toxic compared to CuO 
micrometer-sized particles. One key mechanism may be the ability of CuO NPs to damage the 
mitochondria. In contrast, micrometer-sized particles of TiO2 caused more DNA damage 
compared to the NPs, although this may be explained by differences in their crystal structures. 
The iron oxides showed low toxicity and no clear difference between the different particle sizes.  
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Singh et al [126] studied Fe2O3 (< 50 nm) - and Fe2O3-bulk (< 5 μm) particles in female Wistar 
rats. The genotoxicity was evaluated at 6, 24, 48 and 72 hours by the comet assay in leucocytes, 
at 48 and 72 hours by the micronucleus test in peripheral blood cells, at 18 and 24 hours by the 
chromosomal aberration assay in bone marrow cells and at 24 and 48 hours by the 
micronucleus test in bone marrow cells. The tail DNA (comet), frequencies of micronuclei 
(micronucleus test) and chromosome aberrations were statistically insignificant (p>0.05) at all 
doses. These results suggested that 30nm and bulk Fe2O3 were not genotoxic at the doses 
tested.  
In a similar study, Singh et al [128] assessed MnO2 nano- (45 nm) and micrometer-sized particles 
(< 5 μm). Nano-MnO2 elicited genotoxicity in rats as determined using the micronucleus test, 
comet and chromosomal aberration assays at 1000 mg/kg but bulk particles did not. A 
significant (p < 0.05) increase in the percentage tail DNA was observed in the peripheral blood 
leukocytes (PBLs) of rats exposed to MnO2-45 nm at the highest dose of 1000 mg/kg body 
weight at 24 and 48 h sampling times; however, no significant DNA damage was observed at 6 
and 72 h. In rats treated orally with 100, 500 and 1000 mg/kg body weight of MnO2-bulk 
particles at 6, 24, 48, and 72 h, no significant DNA damage was observed. Moreover, there was 
a clear size dependent biodistribution as well as toxicity. These findings support the view that 
NMs may have both higher toxicity and distribution rates compared to their bulk counterparts. 
Midander et al  [113] assessed the toxic aspects of nano-sized (50 nm) and micrometer-sized 
(<10 μm)  particles of copper(II) oxide in contact with cultivated lung cells. The nano-sized 
particles caused a higher degree of DNA damage (single-strand breaks) and caused a 
significantly higher percentage of cell death than micrometer-sized particles. Since these 
authors also observed higher release of copper for the nano-sized particles, under similar 
conditions to the toxicity assays, their results suggest that both the observed genotoxicity and 
cytotoxicity were caused by the release of copper from the particles. 
In another comparative study by Guichard et al [253], commercially available nanosized (<90 
nm) and microsized (<0.75 μm) anatase TiO2, rutile TiO2, Fe3O4, and Fe2O3 particles were 
compared in Syrian hamster embryo (SHE) cells. Similar levels of DNA damage were observed in 
the comet assay after 24 h of exposure to anatase NPs and microparticles. Rutile microparticles 
were found to induce more DNA damage than the nanosized particles. However, no significant 
increase in DNA damage was detected from nanosized and microsized iron oxides. None of the 
samples tested showed significant induction of micronuclei formation after 24 h of exposure.  
Balasubramanyam et al. stated that [81], Al2O3-bulk particles (50–200 μm) did not induce 
statistically significant changes over control values when assessed via the comet assay. The 
nanosized Al2O3 however, produced a genotoxic effect in the comet assay. 
76 
 
The studies highlighted above suggest that (at least in terms of their genotoxic effects) NPs do 
not always have higher toxicity than micrometer-sized particles or their bulk counterparts of 
the same chemical composition. However, the higher toxicity of some NPs compared to their 
micrometer-sized counterparts arguably justifies caution when moving from the micrometer to 
nanometer scale. 
One important issue needs to be appreciated. Although the number of studies on the 
genotoxicity of metal oxide/silica NMs is increasing, many results are inconsistent and need to 
be confirmed by additional experiments. In previoous sections we have discussed the results 
that may be conflicting, but overall, show some trends in metal oxides NMs’ genotoxicity. We 
assume that experimental data for NMs of the same core chemical composition may vary to 
some extent because of the following reasons, along with other possible variations: 1) various 
average sizes of NMs used; 2) various size distributions; 3) various purity of NMs; 4) various 
surface areas of NMs with the same average size; 5) different coatings; 6) differences in crystal 
structures of the same types of NMs; 7) different sizes of aggregates in different media; 8) 
differences in assays; 9) different concentrations of NMs in assay tests; 10) variation in 
concentration of analytes in assays. The situation of conflicting reports (experimental data) and 
inherent problems with nanotoxiclogy studies was discussed in the following publications [254-
259]. For example, in a recent research article [255], the authors evaluated publications related 
to engineered NMs’ safety assessments where evaluation was spurred by conflicting reports 
demonstrating different degrees of toxicity with the same NMs. They found that that ca. 95% of 
papers from 2010 using biochemical techniques to assess nanotoxicity did not account for 
potential interference of NMs (i.e. interference of NMs properties with analytical techniques), 
and this number had not substantially improved in 2012. Based on these findings, they 
provided recommendations for authors of future nanotoxicology studies [255]. 
 
6.2. Discussion of results from the experimental studies for each type of metal oxide/silica 
NM  
The 165 publications obtained from the literature search refer to nano oxides of different 
metals (cerium oxide, copper oxide, iron oxides, titanium oxide, nickel oxide, manganese oxide, 
magnesium oxide, cobalt oxide, bismuth oxide, and zirconium oxide) as well as silica (silicon 
dioxide). The data obtained using the comet and micronucleus assay are summarized in Table 1 
and Table 2 respectively. The experimental protocols clearly differ in many respects. The main 
differences between the different studies are the heterogeneity of cell types and methods 
used. In addition, the nano-sized metal oxides/silica were of varying sizes etc. Nonetheless, in 
spite of this inconsistency, it is possible to draw some general findings in some cases. The Ames 
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test results are reported in Table 3. The number of studies concerning this test on NMs is low. 
Furthermore, a few studies consider Ames test not appropriate for NMs [52]. 
Overall genotoxicity of each nano metal oxide/silica considering the data gathered in this 
review: 
Comet assay results were as following for each compound (Table 1): 
Al2O3  
Results from the comet assay are reported in three publications [81, 103, 104]. In two in vitro 
studies [103, 104] this nano metal oxide gave different outcomes; it increased the DNA damage 
significantly comparing to control in mouse lymphoma (L5178Y) cells and human bronchial 
epithelial (BEAS-2B) cells and had no significant effect on human embryonic kidney (HEK293) 
cells and peripheral blood lymphocytes. The third publication reported an increase in DNA 
damage in an in vivo test [81]. 
Bi2O3 
One publication [105] reports that DNA damage in the root cells of Allium cepa for different 
concentrations of the NM (25, 50, 75, 100 ppm) exhibit statistically significant differences 
compared to the control.  
CeO2 
Reports are provided in seven publications of the comet assay being employed to assess NMs of 
CeO2. The type of cells and duration of exposure varied. Each study was performed on a 
different cell type and exposure criteria. This might explain the contrasting results: five 
publications [92, 106, 107, 109, 111] reported a positive comet assay outcome and two [108, 
110] did not report significant genotoxic effects. However, another possible explanation for the 
contrasting results could be differences in size or surface functionalization etc. 
Co3O4 
Two publications have reported genotoxic effects observed in comet assay for NMs of this 
cobalt oxide [109, 112].  
CuO 
In ten publications (on human lung epithelial cells (A549) cells and human murine macrophages 
cells (RAW)) the CuO NMs ranging in size from 10-100nm, induced DNA strand breakages as 
assessed by the alkaline comet assay [31, 113-118, 120-122]. A publication reported no 
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genotoxicity observed following exposure to the metal oxide in aquatic organism (Macoma 
balthica) [119].  
Fe2O3 
Reports in seven publications stated that Fe2O3 of different dimensions and preparations 
elicited no significant genotoxic effect as determined with the alkaline comet assay [31, 114, 
123, 124, 126, 127]. However, in one publication [31], these kinds of particles were found to be 
genotoxic according to the comet assay. 
Fe3O4 
Six publications conducted on A549 and BEAS-2B cells and human lymphocytes reported that 
these kinds of nano particles induced DNA breakages as detected by the comet assay [109, 129-
132, 260]. Three publications reported no genotoxic effect of which one study conducted on 
peripherial blood lymphocytes HEK293 and HPL cells showed no significant genotoxicity at all 
concentrations after 1 h incubation with both types of cells [123] and no DNA damage was 
observed at the tested concentration levels on in vitro human lung type II epithelial  (A549) cells 
in two studies [31, 114]. 
MnO2 
Two publications report the in vivo genotoxic effects of the MnO2 nano metal oxides: A 
statistically significant (p < 0.05) increase in the percentage of tail DNA was observed in the 
PBLs of rats exposed to MnO2-45 nm at the highest dose of 1000 mg/kg body weight at 24 and 
48 h sampling times; however, no significant DNA damage was observed at 6 and 72 h [128]. 
Singh et al [134] reported a statistically significant (P < 0.01) increase in the DNA damage 
(percentage of tail DNA) with the highest and medium doses. No significant increase was found 
with the lowest dose. 
NiO 
One publication has reported genotoxic effects observed in comet assay for NPs of NiO [109]. 
MgO 
Particle-induced DNA strand breakage and oxidative DNA damage in Caco-2 cells was detected 
using the FPG variant of the comet assay. DNA strand breakage and oxidative DNA damage was 
determined in Caco-2 cells by the FPG-modiﬁed comet  assay following 4 h treatment at 20 
mg/cm2. After treatment, all samples were processed in the comet assay. MgO produced no 
significant change compared to the control [133] . 
SiO2 
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Fifteen publications were obtained for silica, with different crystalline structures (amorphous 
and quartz forms) as well as differences in surface functionalization. These studies showed the 
genotoxic [55, 82, 140, 142, 144] or non- genotoxic behavior of this NM [109, 111, 133, 135-
144]. 
TiO2 
Fifty three publications were retrieved for titanium dioxide NMs [31, 85, 87, 89, 103, 111, 114, 
121, 123, 125, 133, 146-168, 170-176, 178-180, 182-186, 249, 261-263]. These studies included 
data on different forms of TiO2, such as anastase, rutile and the mixture of both forms. 
Genotoxic effects, as determined with the alkaline comet assay, were observed in forty of these 
publications - whilst the other thirteen detected no significant genotoxic effect for this kind of 
NMs. 
V2O3 and V2O5 
One study has reported genotoxic effects observed in comet assay for NPs of V2O3 and no 
genotoxic effects of V2O5 [52]. 
ZnO 
Twenty one comet publications were found for these nano metal oxides [55, 114, 121, 133, 
152, 155, 156, 159, 165, 186-196]. Genotoxic effects were observed in CaCo-2 cells [133], 
lymphocytes and sperm cells [155], A549 [114, 152], human epidermal cell line [189], primary 
mouse embryo fibroblasts [55], HK2 cells [186]. Among all the studies, two reported non-
genotoxic results from the comet assay, where the size of agglomerates was about 200nm [191, 
192]. The large size (over 100nm) of NPs studied is one possible reason of non-genotoxic results 
and therefore it is questionable if these results are truly relevant for most NPs. 
ZrO2 
In a single publication performed on nano metal oxides of ZrO2, no significant induction in DNA 
damage by the comet assay was observed with or without the Endo III and FPG enzymes at all 
concentrations. 
 
Micronucleous test results for each compound (Table 2): 
 
Al2O3  
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Two publications reported positive results in the in vivo micronucleous assays on the same type 
of Al2O3 NMs (30-40 nm Nominal size). One publication reported results of the test performed 
after oral administration in bone marrow cells [197]. The other publication reported resultson 
peripherial blood cells after gavage administration [81].  
CeO2 
In two publications [106, 107] genotoxic effects of these NMs were observed for the 
micronucleous assay on in vitro human cells (dermal fibroblasts and neuroblastoma). 
CuO 
In two publications in vitro micronucleous test results reported genotoxic effects of these NMs 
[115, 198]. Song et al [86] reported an in vivo micronucleous test genotoxic outcome.   
Fe2O3 
Two publications  reported results of in vivo micronucleous assay for this compound; whereas 
one paper reported statistically insignificant results [126], the other publication reported 
genotoxic effects for these NMs [86]. The studies were conducted on albino Wistar female rat 
peripheral blood and bone marrow cells and female ICR mice peripheral blood cells. 
Fe3O4 
Three publications reported results of the micornucleous assay, a study conducted in vivo on 
female ICR mice peripheral blood cells identified significant increases in micronucleated 
reticulocytes cells [131]. Chen et al. found no significant difference between the test animals 
and the negative controls in the In vivo kunming mice bone marrow cells [199]. Song et al. 
observed a significantly enhanced MN induction on human lung adenocarcinoma type-II 
alveolar epithelial cells A549 (in vitro) at 10 μg/cm2 [86]. 
MnO2 
In a study performed by Singh et al [128] the micronucleous assay conducted on bone marrow 
cells extracted from the femurs of female albino Wistar rats (in vivo) the data revealed 
statistically significant enhancement in the MN frequency in the groups treated with 1000 
mg/kg body weight of MnO2-45 nm at 24 and 48 h of sampling times. 
SiO2 
Micronucleous assay was reported in five publications on different crystalline structures. These 
studies reported genotoxic [201, 202] and non genotoxic [138] [200] effects of these NMs. One 
publication showed equivocal results [82]. 
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TiO2 
Micronucleous assay was reported in fourteen publications. Among these, in five non-genotoxic 
effects were observed [148, 172, 203, 204, 207] and genotoxic effects in the remaining studies 
[86, 137, 146, 147, 169, 199, 200, 205, 206]. 
For a detailed report on genotoxicity of these nanoparticles see reviews [264, 265]. 
V2O3 and V2O5 
No induction of the micronuclei has been observed for NPs of V2O3 and V2O5 [52]. 
ZnO 
Four publications reported micronucleous test results for these NMs: An in vivo study, 
described in [191], on mice bone marrow cells reported non-genotoxic micronucleous test 
results. In three publications [16, 200, 209] in vitro studies on different cells (A549 human lung 
carcinoma cells 199, A549 human lung carcinoma cells, and A. cepa root cells) showed negative, 
positive and equivocal results. In one of these  in vitro studies [209] coated and uncoated nano 
ZnO were tested. The uncoated ZnO NMs were not genotoxic in the micronuclei assay. The 
coated ZnO was, however, genotoxic.  
WO3 
One publication [83] reported micronucleous test conducted on the nanoparticles of WO3. No 
statistically significant difference was found between 25 mg WO3 applied and control group. On 
the contrary, the higher doses of WO3 (50 and 100 mg) caused increases of MN rates. No 
characterization of the NMs was reported in the paper. 
 
Ames test results; an overall view (Table 3): 
Mutagenicity assessed by the Ames test is reported in Table 3. Al2O3, Co3O4, Fe3O4 tested on 
various strains of S. typhimurium and E. coli, with and without metabolic activation gave 
negative results in Ames test. Fe3O4 was reported in one publication to be positive in the Ames 
test. Nano TiO2 in four publications gathered in this review, showed at least one positive result 
in Ames test. Woodruff et al [174] reported negative mutagenicity of the nano TiO2. Hasegawa 
et al [216] reported positive Ames results for nano WO3, In2O3, and Dy2O3. In two publications 
ZnO was found to have positive Ames test data results and to be negative in three other 
publications. 
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7. Conclusions 
The number of published genotoxicity studies on metal oxide/silica NMs is still limited, although 
this endpoint has recently received more attention for NMs and the number of related 
publications has increased. However, more, well designed, genotoxicity studies are required, 
with a particular need for more in vivo experiments. We can expect an increasing number of 
genotoxicity studies of NMs, with our literature analysis showing an increasing number of 
genotoxicity publications every year. In particular, we can see that the number of papers 
reporting comet assay studies for NMs is increasing year on year, although this is not true for 
the micronucleus test which was the second most popular test amongst those considered in 
this review. Among the other two tests considered in this review, the Ames and chromosome 
aberration tests, the former is much more popular for NMs analysis and its use is increasing, in 
spite of concerns raised about the validity of the Ames test for NMs, whilst the use of the latter 
would seem to be decreasing in popularity for nanomaterials. Although the number of studies 
of the genotoxicity of metal oxide/silica NMs is increasing, many results, for the same core 
chemical composition, are inconsistent: these may need to be confirmed by additional 
experiments or they may reflect genuine differences due to differences in particles sizes, 
functionalization etc. In this review, we have discussed the results that may be conflicting. We 
assume that experimental data for genotoxicity, for NMs with the same core chemical 
composition, may vary to some extent because of the following reasons: 1) various sizes of NPs 
used; 2) various size distribution; 3) various purity of NMs; 4) various surface areas for NMs 
with the same average size; 5) different coatings; 6) differences in crystal structures of the same 
types of NMs; 7) different sizes of aggregates in solution/media; 8) differences in assays; 9) 
different concentrations of NMs in assay tests; 10)  variation in concentration of analytes in 
assays etc. The experimental data in the public domain are still quite scarce and exhibit 
considerable heterogenity. Ideally, all experimental studies would need to be performed using 
the same protocol to be able to properly compare these data. As a result of these issues, the 
genotoxicity data for NMs are quite difficult to compare and make robust conclusions. 
As can be seen from the above discussion, different kinds of metal-oxide/silica NMs exhibited 
varying degrees of genotoxicity. In the majority of the literature references analysed, the NMs 
considered caused DNA strand breaks or oxidative DNA lesions. Our analysis of these data 
shows that NMs based on ZnO, NiO, CuO, V2O3, Al2O3, TiO2 exhibited at least one positive 
genotoxic response in most of the references analyzed, while Fe2O3 and SiO2 based NMs mainly 
showed non-genotoxic responses in these references. Nonetheless, caution is advised regarding 
these generalizations as considerable inconsistency in the experimental protocols was observed 
as well as variation in the characteristics of the studied NMs, of any given chemical 
composition, such as particle size, functionalization etc. In addition to considering the outcome 
of the tests (i.e. “positive” or “negative” study calls), it should be noted that metal oxide/silica 
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NMs may induce genotoxicity via various mechanisms. For example, metal oxide NMs may 
induce genotoxicity via primary or secondary ROS generation pathways. There is a great need 
for careful scrutiny of the genotoxicity of metal oxide/silica NMs at the molecular level.  
This review should help to improve genotoxicity testing of metal oxide/silica NMs, as well as 
help in understanding of mechanisms and, crucially, provides a valuable summary of 
genotoxicity data for these NMs reported in the literature up until July 2014. 
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